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Neisseria gonorrhoeae is the causative agent of the sexually transmitted infection, 
gonorrhoea. In a standard infection, N. gonorrhoeae invade epithelial cells lining 
the urogenital tract and exit into the sub-epithelial layer. This triggers an immune 
response that causes the noticeable symptoms of gonorrhoea. Asymptomatic 
infection occurs when the bacteria persist inside epithelial cells, avoiding detection 
by the human immune system. Bacterial persistence has been linked to the 
development of antibiotic resistance, and as such, is a major contributing factor to 
the success of the pathogen. Mechanisms of adherence and invasion by 
N. gonorrhoeae have been well researched, but little is known about the 
intracellular lifecycle of the bacteria during infection and persistence. 
Toxin-antitoxin (TA) systems have been linked to the formation of persistent 
populations in bacteria however the role of TA systems in N. gonorrhoeae is yet to 
be investigated. In this thesis, the role of a VapBC TA system in intracellular 
replication of N. gonorrhoeae is investigated and activity of the toxic VapC protein 
is characterised. The TA system, FitAB, is a protein-protein complex comprised of 
an antitoxin, FitA, and a toxin, FitB. Activity of FitB is inhibited when in complex 
with FitA, and the complex is auto-regulatory. Biochemical activity screens using 
RNA pentaprobe substrates to characterise the activity of FitB show FitB cleaves 
single-stranded RNA pentaprobes. However, FitB does not cleave short RNA 
oligonucleotides of the same sequence(s). These results indicate FitB is a 
magnesium-dependent sequence-specific ribonuclease that cleaves RNA based on 
sequence and secondary structure.  
The potential role of FitAB in persistence of N. gonorrhoeae was investigated using 
intracellular replication experiments. Intracellular replication of a N. gonorrhoeae 
fitAB gene deletion strain showed the most pronounced phenotype seen for a single 
TA deletion.  Intracellular replication of the fitAB gene deletion strain is 
considerably faster than the wild-type within epithelial cells. However, a sudden 
cell death event occurs in the gene deletion strain suggesting the TA system is 
essential for sustainable, long-term growth during infection. An understanding of 
how FitAB regulates intracellular growth will provide insight into the intracellular 
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1 Chapter One 
Introduction 
Gonorrhoea is a prevalent sexually transmitted infection caused by the pathogenic 
gonococcus (GC), Neisseria gonorrhoeae. Gonorrhoea has become a global health 
crisis with its high prevalence in the global population and the rapid development 
of resistance to antibiotics (Edwards & Butler, 2011). There is a pressing need to 
understand the mechanisms behind GC infection so alternative antimicrobial 
treatments can be designed. Much research has been carried out regarding the 
pathobiology of the infection (Edwards & Butler, 2011), as well as gonococcal 
invasion mechanisms (Hill et al., 2016) and interaction with the host immune 
system. Little is understood, however, about the intracellular lifecycle of the 
pathogen. It is apparent that N. gonorrhoeae can persist inside the host like other 
pathogenic microorganisms, which contributes to survival of the pathogen and may 
be linked to the development of antibiotic resistance. My research aims to 
characterise a toxin-antitoxin system in N. gonorrhoeae and its potential role in 
persistence. 
1.1 Gonorrhoea: the disease and the threat of antibiotic resistance 
N. gonorrhoeae is estimated to cause over 78 million infections worldwide, 
annually (Newman et al., 2015). Initially, when GC infect the lower urogenital tract 
it causes uncomplicated cervicitis in women and urethritis in men, which are local, 
self-limiting infections that present observable symptoms (Unemo & Shafer, 2014). 
In some cases infection can be asymptomatic and these typically go untreated 
(Edwards & Butler, 2011; Holmes et al., 1971). If left for a long period of time GC 
can ascend into the upper urogenital tract, causing more complicated infection such 
as endometritis, pelvic inflammatory disease and epididymitis, which can lead to 
infertility and ectopic pregnancy (Holmes et al., 1971; Hopper et al., 2000; World 
Health Organization, 2011). Subclinical infection disproportionately affects men 
and women, occurring in 10% and 50% of cases respectively (Workowski & 
Berman, 2007). Asymptomatic, subclinical infection is still transmissible and as 
such is a major contributing factor to the spread and success of the pathogen, and 
the emerging resistance to antibiotics (Edwards & Butler, 2011; Workowski & 
Chapter One: Introduction 
2 
Berman, 2007). N. gonorrhoeae is rapidly developing resistance to frontline 
antibiotics used worldwide, with most strains displaying reduced susceptibility to 
all currently available treatment options (Unemo, 2015; Wi et al., 2017). Infection 
was initially treated with sulphonamides, penicillins, tetracyclines, macrolides, 
fluoroquinolones and cephalosporins until resistance emerged and spread globally 
(Unemo, 2015; Wi et al., 2017). An extended-spectrum cephalosporin, ceftriaxone, 
is still used in some countries as a monotherapy treatment option, however reduced 
susceptibility has been identified in strains from the USA and more locally in 
Canterbury, Auckland and Waikato District Health Boards within New Zealand 
(Alirol et al., 2017; ESR., 2014; Wi et al., 2017). In recent years, a dual-therapy 
approach, in which two or more antibiotics are used together, most commonly 
ceftriaxone and azithromycin, has been implemented in an attempt to combat 
resistance (Wi et al., 2017; Workowski et al., 2015). In February 2018, a strain was 
isolated from an infected individual in the UK which showed dual-resistance to 
ceftriaxone and azithromycin combined therapy (Eyre et al., 2018). Other strains 
identified in the USA also show total resistance and have been classified by the 
World Health Organisation as ‘Superbugs’ (Wi et al., 2017).  
It is evident that antibiotic resistance of N. gonorrhoeae is a global crisis that 
requires the development of new antibiotics and new treatment regimens to 
overcome. Understanding gonococcal infection and how the bacteria are capable of 
developing resistance so rapidly is fundamental to this development.  
1.2 Gonococcal mode of infection 
GC predominantly infect epithelial cells that line the urogenital tract. Although not 
completely defined, the mode of adherence by GC is specific to cell type, site of 
infection, and gender (Edwards & Apicella, 2004). To invade epithelial cells, GC 
use Type IV pili and various outer membrane proteins to form a tight association 
with the cell (Edwards & Butler, 2011; Swanson et al., 1987). The bacteria are 
engulfed into the cell inside a vacuole like structure (Edwards & Butler, 2011). 
Once inside the host cell, GC either remain on the periphery of the cell and can be 
recycled back out the apical side of the epithelium, or they traffic to the basolateral 
side of the cells and are exocytosed into the sub-epithelial layer (Figure 1-1) (Billker 
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et al., 2002; Evans, 1977; Wang et al., 1998). In some infections, N. gonorrhoeae 
remains inside the mucosal cells in a dormant state (Hopper et al., 2000). 
 
Figure 1-1.Schematic diagram of GC infection. Diploid GC makes contact with 
receptors on the mucosal cell surface via Type IV pili. The pili retract to strengthen 
attachment between the bacteria and the cell surface. GC are then internalised into 
the cell where they either remain inside in a persistent state or transcytose through 
the basolateral side into the subepithelial layer. Human immune cells detect GC in the 
subepithelial layer, trigger and immune response and generate symptoms. Figure 
adapted from (Hill et al., 2016). 
Due to the nature of GC infection, observable symptoms such as pustular discharge 
and inflammation are only generated when the bacteria are attacked by the human 
immune system (Hill et al., 2016). Immune response is triggered when the bacteria 
attach to the mucosal cells or when they enter the sub-epithelial layer (Hill et al., 
2016). Recruitment of pro-inflammatory cytokines and neutrophils to the site of 
infection cause the observable symptoms (Fisette et al., 2003; Ramsey et al., 1995). 
If N. gonorrhoeae is in a persistent state, no immune response is triggered and thus 
infection is asymptomatic (Workowski & Berman, 2007).  
Persistent bacteria are a subpopulation of bacteria that differentiate into a dormant 
state where they do not actively divide (Balaban, 2011; Bigger, 1944). This 
increases survival of the population during adverse and stressful conditions such as 
nutrient starvation and antibiotic exposure (Balaban, 2011; Bigger, 1944). Bacteria 
displaying the persistent phenotype avoid exposure to antibiotics and have a higher 
tolerance because the cellular processes involved in replication and division that are 
targeted by antibiotics are downregulated so antibiotics have no effect (Balaban, 
2011; Lewis, 2010; Maisonneuve & Gerdes, 2014; Tuomanen, 1986). This is in 
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contrast to antibiotic resistant phenotypes which act by preventing the antibiotic 
from binding to its target (Lewis, 2010). Once the antibiotic threat is gone, the 
dormant subpopulation can actively divide again to repopulate the environment 
(Balaban, 2011). As N. gonorrhoeae is naturally transformable, it readily accepts 
antibiotic resistant plasmids which may be present during periods of persistence, 
leading to a resistant phenotype of the new population (Ochman et al., 2000). 
Toxin-antitoxin (TA) systems have been linked to bacterial persistence in other 
pathogenic bacteria (Amitai et al., 2009; Keren et al., 2011) and associated with 
cellular trafficking of N. gonorrhoeae (Hopper et al., 2000). As such, the role of 
TA systems in persistence of N. gonorrhoeae warrants investigation. 
1.3 Toxin-Antitoxin Systems 
TA systems are complexes found in many prokaryotes and archaea to mediate 
chromosomal stabilisation, plasmid maintenance, and enhance survival during 
infection (Gerdes et al., 1986; Lobato-Márquez et al., 2016). The complexes 
comprise a stable toxin which is inhibited by a less stable antitoxin (Arcus et al., 
2011). The toxin and antitoxin are translationally coupled on an auto-regulated, 
bicistronic operon (Anantharaman & Aravind, 2003). Due to the antitoxin being 
relatively unstable, eventually it degrades, leaving the toxin uninhibited (Ahidjo et 
al., 2011; Gerdes et al., 1986; Hayes, 2003). On its own, the toxin is responsible for 
targeting key physiological processes to inhibit cell growth or induce cell death 
(Yamaguchi & Inouye, 2011). 
The repertoire of biological functions of TA systems is continually expanding as 
more systems are discovered and characterised. The first TA systems described 
were labelled plasmid maintenance modules as they mediated the survival of cells 
that contained the plasmid on which they were encoded (Gerdes et al., 1986; 
Lobato-Márquez et al., 2016). Upon bacterial replication, if daughter cells did not 
contain the plasmid, the antitoxin and toxin could not be synthesised. As the toxin 
is more stable than the antitoxin, the antitoxin would degrade leaving active toxin 
to arrest cell growth and cause cell death, thus eliminating the cells lacking the 
plasmid in a process termed ‘post-segregational killing’ (Gerdes et al., 1986). With 
the era of genome sequencing, came the discovery of TA systems encoded on 
chromosomes (Gerdes et al., 2005; Pandey & Gerdes, 2005). Some of these systems 
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were found within or linked to mobile genetic elements (MGE) (Cambray et al., 
2010). The function of these systems was proposed to be for maintenance of the 
MGEs much like the plasmid maintenance TA modules (Hernández-Arriaga et al., 
2014). There was, however, a greater abundance of chromosomal TA systems not 
associated with MGEs. These were proposed to function as stress-response 
elements, regulating cell growth in response to environmental stressors (Gerdes, 
2000). Over recent years, with the use of genome sequencing and bioinformatics, a 
vast array of TA systems have been discovered throughout the prokaryotic kingdom. 
The function of which, has been characterised for a number of systems (Gerdes et 
al., 2005; Harms et al., 2018; Lee & Lee, 2016) while inferred for others based on 
classification criteria.  
TA systems are classified into six ‘types’ based on the nature and role of the 
antitoxin (Lobato-Márquez et al., 2016; Page & Peti, 2016). Type I systems have 
small antisense RNA antitoxins that prevent translation of the corresponding toxin. 
Type II have protein antitoxins that neutralise the protein toxin and bind upstream 
of the operon to repress transcription (Lobato-Márquez et al., 2016; McKenzie, 
2011). Type III TA systems have small RNA antitoxins that neutralise the toxin by 
inhibiting its RNase activity (Fineran et al., 2009). Type IV, V and VI systems all 
have proteinaceous antitoxins. The antitoxins of type IV and V systems act on the 
target of the toxin to inhibit activity while those of type VI systems bind directly to 
the toxin, promoting protease degradation (Lobato-Márquez et al., 2016).  
Type II TA systems are of particular interest to this project because they have been 
associated with bacterial persistence by controlling intracellular growth (Amitai et 
al., 2009; Hopper et al., 2000). Within this group of TA systems, there are 12 super-
families which are identified based on the nature of the toxin. These superfamilies 
are CcdB, Doc, HicAB, HigBA, MazEF, ParDE, VapBC, VapXD, RelBE, YafNO, 
and ωεζ (Leplae et al., 2011). Multiple TA operons can be found in a single 
organism, differing in number of copies, the family they belong to and whether they 
are of chromosomal or plasmid origin (Pandey & Gerdes, 2005). The human 
pathogen, Mycobacterium tuberculosis, for example, has approximately 80 putative 
TA systems, most of which are Type II systems belonging to several well 
characterised super-families; 50 VapBC, ten MazEF, two RelBE, two HigBA, two 
ParDE (Sala et al., 2014). In contrast, N. gonorrhoeae has six Type II TA systems: 
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one VapBC, three RelBE, one MazEF, one HicAB (Shao et al., 2011). The 
assortment of TA systems present in a genome can also differ between strains 
within a species, for example, N. gonorrhoeae strain FA1090 lacks two of the three 
RelBE systems found in all other known strains of N. gonorrhoeae (Shao et al., 
2011). 
1.4 Type II TA Systems in N. gonorrhoeae 
The Type II TA systems in the N. gonorrhoeae chromosome include MazEF, 
RelBE, HicAB and VapBC (Shao et al., 2011). To date, there is very little known 
about the role of these TA loci in N. gonorrhoeae, however, in other prokaryotes, 
particularly E. coli, these TA systems have been relatively well characterised. The 
structural and functional role of TA loci in other prokaryotes provides an 
understanding of the potential function of the homologous loci in N. gonorrhoeae. 
This section provides a general description of these TA systems in other 
prokaryotes. 
1.4.1 MazEF 
The MazEF TA system has been well studied in many bacteria including E. coli 
(Kamada et al., 2003; Zhang et al., 2003), Pseudomonas putida (Miyamoto et al., 
2016) and M. tuberculosis (Mittenhuber, 1999; Zhu et al., 2006). The mazEF 
operon encodes the antitoxin MazE and the toxin MazF (Aizenman et al., 1996). 
Two MazE proteins interact with four MazF proteins to form a stable 
heterohexamer which autoregulates transcription by binding to palindromic repeats 
in the promoter region of the mazEF operon (Aizenman et al., 1996; Kamada et al., 
2003). During periods of stress, such as nutrient deprivation, heat shock and 
antibiotic exposure (Hazan et al., 2004), MazE is degraded by the ClpPA protease, 
releasing active MazF which leads to programmed cell death or inhibition of cell 
growth (Aizenman et al., 1996; Kamada et al., 2003). MazF proteins are ribosomal-
independent ribonucleases which inhibit cell growth by cleaving mRNA transcripts 
in a sequence-specific manner (Miyamoto et al., 2016; Zhang et al., 2003). E. coli 
MazF targets the RNA triplet sequence ACA (Zhang et al., 2003) while the MazF 
homologue from P. putida targets the RNA sequence UAC (Miyamoto et al., 2016). 
Despite different target sequences, cleavage of mRNA transcripts by both MazF 
proteins interrupts protein synthesis (Miyamoto et al., 2016; Zhang et al., 2003). 
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The synthesis of large survival proteins is inhibited while the synthesis of death 
proteins is increased leading to death of a large portion of the population. 
Uninterrupted expression of small survival proteins, however, allows a small sub-
population to survive in a persistent state (Amitai et al., 2009; Miyamoto et al., 
2016; Zhang et al., 2003). This bacteriostatic effect of MazF is important for the 
ultimate survival of the population during periods of stress (Amitai et al., 2009).  
1.4.2 RelBE 
The relBE operon encodes an antitoxin, RelB, and a toxin, RelE which assemble 
into a heterotetramer (Mattison et al., 2006; Pedersen et al., 2002). The relBE 
promoter is repressed during steady-state growth by the RelBE complex 
(Christensen et al., 2001). Under amino-acid starvation, RelB is degraded by the 
Lon protease and transcription is upregulated causing an abundance of RelE 
(Christensen et al., 2001). In E. coli, RelE inhibits protein synthesis by cleaving 
mRNA at the ribosomal A-site during translation (Christensen & Gerdes, 2003). 
Global inhibition of translation prevents cell proliferation and colony formation, 
making the cells bacteriostatic during periods of starvation so they can return to an 
active state when the nutrients are replenished (Christensen et al., 2001; Pedersen 
et al., 2002).  
1.4.3 HicAB 
HicAB was first discovered in Haemophilus influenza as two conserved open 
reading frames in a major pilus gene cluster (Mhlanga-Mutangadura et al., 1998), 
but was later identified as a TA system using a computational comparative-genome 
approach (Makarova et al., 2006). The function and structure of HicAB has since 
been studied in E. coli (Jørgensen et al., 2009), Burkholderia pseudomallei (Butt et 
al., 2014; Winter et al., 2018), Streptococcus pneumonia (Kim et al., 2018), and 
Yersinia pestis (Bibi-Triki et al., 2014). 
Unlike the other Type II TA systems, the gene encoding the toxin (hicA) precedes 
the gene encoding the antitoxin (hicB) in the hicAB operon (Jørgensen et al., 2009; 
Makarova et al., 2006). Despite this difference, the mechanisms of the toxin and 
antitoxin proteins when expressed are similar to that of MazEF and RelBE TA 
systems (Jørgensen et al., 2009). The HicAB complex is assembled by a HicB 
homo-dimer binding to two or more HicA monomers (Bibi-Triki et al., 2014; Kim 
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et al., 2018). The N-terminal region of HicB binds to HicA to neutralise activity 
while the C-terminal region of HicB contains a ribbon-helix-helix (RHH) DNA-
binding domain which binds to DNA in the promoter region of the hicAB operon to 
regulate transcription (Jørgensen et al., 2009; Kim et al., 2018; Makarova et al., 
2006). During periods of nutritional stress, HicB is degraded by Lon proteases, 
inducing transcription of the hicAB operon and releasing active HicA (Jørgensen et 
al., 2009). On its own, HicA has ribonuclease activity against specific mRNA 
substrates which inhibits protein translation and consequently impedes cell growth 
and proliferation (Jørgensen et al., 2009).  
1.4.4 VapBC 
The VapBC (virulence-associated protein) TA family is the most abundant Type II 
TA system (Arcus et al., 2005; Gerdes et al., 2005). Toxins are classified as VapC 
if they contain a C-terminal PilT-N (PIN)-domain (Arcus et al., 2011). 
The vapBC operon encodes the antitoxin, VapB, and the toxin, VapC, with 
overlapping open reading frames (Figure 1-2) (Arcus et al., 2011). VapB and VapC 
form a tightly associated dimer where the C-terminus of VapB blocks the active site 
of one or more VapC molecules to form an inert VapBC complex (Maté et al., 2012; 
Mattison et al., 2006; Miallau et al., 2009). VapBC in Rickettsia felis and 
Mycobacterium tuberculosis, assemble as a heterohexamer (Maté et al., 2012; Min 
et al., 2012). One VapB binds to a VapC dimer, blocking both VapC active sites by 
positioning the C-terminal loop in between the dimer interface (Maté et al., 2012; 
Min et al., 2012). In VapBC TA systems from Shigella flexneri and N. gonorrhoeae 
a single VapB molecule blocks the active site of a single VapC molecule and the 
heterodimers form a stable hetero-octamer (Dienemann et al., 2011; Mattison et al., 
2006). To regulate transcription of the vapBC operon, the VapBC complex binds to 
DNA in the promoter region via the RHH DNA binding domain at the N-terminus 
of VapB (Arcus et al., 2011; Dienemann et al., 2011; Gerdes et al., 2005; Maté et 
al., 2012; Mattison et al., 2006; Miallau et al., 2009; Min et al., 2012). As VapB is 
relatively unstable, it is degraded by cellular stress or proteases, enabling 
magnesium-dependent ribonuclease activity of VapC (Figure 1-2) (Clissold & 
Ponting, 2000; Winther & Gerdes, 2012)  
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Figure 1-2. Schematic diagram of the VapBC TA system. VapB (yellow) and VapC 
(blue) are transcribed from a single operon. The VapBC complex binds to DNA in the 
promoter region of the operon to autoregulate transcription. When VapB degrades, 
VapC becomes an active ribonuclease which is toxic to cell growth by way of its 
sequence-specific ribonuclease activity. 
The C-terminal PIN-domain in VapC proteins is important for metal-cation 
dependent ribonuclease activity (Arcus et al., 2004; Clissold & Ponting, 2000; 
Winther & Gerdes, 2011). The structurally conserved PIN-domain fold has a central 
β-sheet made up of five parallel β-strands with α-helices on both sides (Figure 1-3) 
(Matelska et al., 2017; Mattison et al., 2006; Min et al., 2012). The active site is a 
positively charged pocket formed by four highly conserved acidic amino acid 
residues (three aspartate residues and one glutamate residue) (Figure 1-3) at the 
C-terminus of the β-strands (Arcus et al., 2005; Min et al., 2012). The conserved 
residues coordinate either Mg2+ or Mn2+ (Arcus et al., 2004; Bunker et al., 2008; 
Matelska et al., 2017; Mattison et al., 2006; Wall & Kaiser, 1999). 
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Figure 1-3. VapC C-terminal PIN-domain structure and sequence homology. (a) 
Ribbon diagram showing the PIN-domain fold. The five β-strands that make up the 
β-sheet are coloured red, α-helices are coloured teal. Image created in PyMOL using 
PDB file 2BSQ. (b) A structural alignment of PIN-domain structures shows structural 
homology within the core of the PIN-domain. The structurally conserved residues are 
shown in grey labelled in sequence order: A, Asp, B, Glu, D, Asp, E, Asp. Image 
retrieved from (Bunker et al., 2008). (c) Hidden Markov model showing the conserved 
residues in the PIN domain. The size of the letter corresponds to the conservation of 
that amino acid. Retrieved from (Arcus et al., 2011). 
The RNA molecules targeted by VapC differ between VapBC systems within a 
single genome and across prokaryotic domains (Sala et al., 2014; Sharrock et al., 
2018). Research has shown VapC proteins have sequence-specific ribonuclease 
activity (McKenzie et al., 2012b; Sharrock et al., 2018; Winther et al., 2016; 
Winther & Gerdes, 2011).  
The sequence-specificity of VapC proteins from M. tuberculosis, M. smegmatis and 
Pyrobaculum aerophilum has been characterised using the pentaprobe system 
(McKenzie et al., 2012a; McKenzie et al., 2012b; Sharrock et al., 2018). 
Pentaprobes were used as they cover every combination of five bases and can be 
used to construct single-stranded RNA fragments. (Kwan et al., 2003; McKenzie et 
al., 2012a; Sharrock et al., 2018). Pentaprobes that are cleaved by VapC were used 
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to design short oligonucleotides, approximately 30 nucleotides (nt) long, which 
were used for further ribonuclease activity testing (McKenzie et al., 2012a). The 
sequence of the VapC cut site was then identified by matrix associated laser 
desorption ionisation mass spectrometry (MALDI-TOF MS) of the shorter RNA 
oligonucleotides (McKenzie et al., 2012a).  
Using the pentaprobe system and MALDI-TOF MS, VapCMSMEG_1284 from 
M. smegmatis was discovered to have sequence and structural specificity, targeting 
mRNA transcripts with a AUA(U/A) head, a short 3’ RNA hairpin and a G-tail 
(McKenzie et al., 2012b). These results, in conjunction with in vivo analyses, 
revealed VapC in M. smegmatis targets mRNA transcripts involved in metabolism 
to down-regulate carbon transport and glucose metabolism as a way of regulating 
sugar utilisation (McKenzie et al., 2012b). VapCs from M. tuberculosis share the 
same optimal cut site of UA*GG (McKenzie et al., 2012a; Sharrock et al., 2018). 
Due to the abundance of vapBC operons in the M. tuberculosis genome and the 
presence of at least five of these VapC toxins with the same target sequence it is 
suggested that each operon may be activated by different stress conditions (Gupta 
et al., 2017; Sharrock et al., 2018). The target sequence differed for VapCPAE0151 
and VapCPAE2754 from P. aerophilum which were found to cleave G-rich sequences 
where there is a guanine residue directly before the cut site, with a preference for 
the sequence GG*UG (McKenzie et al., 2012a). All the VapC proteins analysed 
using MALDI-TOF MS showed the same mechanism of RNA cleavage, cleaving 
at the phosphodiester bond resulting in a 3’-OH and a 5’-PO4 (Sharrock et al., 2018). 
Using different approaches, many other VapCs from M. tuberculosis have been 
characterised as sequence-specific ribonucleases, targeting tRNAs (Winther et al., 
2016) or 23S rRNA (Winther et al., 2013). A combination of in vivo and in vitro 
analyses, including northern blot and primer extension analysis, revealed 
M. tuberculosis VapC20 targets the Sarcin-Ricin loop of 23S rRNA by recognising 
the SRL stem and cleaving between two essential nucleotides (G2661 and A2662) 
in the loop region (Winther et al., 2013). This loop is essential for processes 
involved in translation so by cleaving it VapC20 inhibits global translation and 
prevents cell growth (Winther et al., 2013). By similar means, other VapCs in 
M. tuberculosis were found to cleave the anticodon-loop of a specific tRNA, 
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preventing amino acids from being introduced to the A site during translation and 
ultimately inhibiting protein synthesis (Winther et al., 2016). 
VapC proteins from Salmonella enterica and from the Shigella flexneri virulence 
plasmid also inhibit global translation by cleaving initiator tRNAs (Winther & 
Gerdes, 2009, 2011). Upon amino acid starvation or the introduction of 
chloramphenicol the VapB antitoxin is subject to degradation and transcription of 
vapBC operon is induced resulting in accumulation of free VapC. Active VapC 
cleaves initiator tRNAfMet, inhibiting protein synthesis and cell growth leading to a 
bacteriostatic state (Winther & Gerdes, 2009, 2011). When environmental 
conditions return to normal, VapB inhibits activity of VapC and the VapBC 
complex inhibits further transcription of the vapBC operon (Winther & Gerdes, 
2009, 2011).  
VapC proteins characterised to date have sequence-specific ribonuclease activity 
that inhibits protein synthesis under conditions of stress (McKenzie et al., 2012b; 
Sharrock et al., 2018; Winther & Gerdes, 2011). Many VapC proteins characterised 
from pathogenic bacteria show ribonuclease activity leads to formation of persistent 
populations (Keren et al., 2011; Sharrock et al., 2018; Winther & Gerdes, 2011). 
The VapBC TA system in N. gonorrhoeae may be playing a similar role during 
gonococcal infection. 
1.5 FitAB: a VapBC TA System in N. gonorrhoeae 
The VapBC TA system in N. gonorrhoeae FitAB is named after a fast intracellular 
trafficking phenotype observed upon discovery. The fitAB operon was identified in 
a transposon mutagenesis study, screening for molecular mechanisms that affect 
growth and transcytosis of GC in epithelial cells (Hopper et al., 2000). Transposons 
were randomly inserted into the genome of N. gonorrhoeae and the rate of 
transepithelial trafficking (transcytosis) across polarised T84 monolayers was 
measured. Two transposon insertions knocked out expression of the fitAB operon 
and resulted in increased rates of transcytosis compared to N. gonorrhoeae wild-
type (WT) (Hopper et al., 2000). One transposon insertion, labelled A9, was 
inserted upstream of the ribosomal binding site of fitA, knocking out gene 
expression of both fitA and fitB (Figure 1-4). The other insertion, labelled A1, was 
inserted within the fitB gene, knocking out expression of fitB (Figure 1-4). 
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Figure 1-4. Labelled nucleotide sequence of the fit operon showing locations of the 
transposon mutations. The DNA sequence is numbered on the left. Genes are labelled 
and underlined: fitA (red), fitB (blue). The single-nucleotide where the stop codon of 
fitA and the start codon of fitB overlaps is in bold. The inverted-repeat sequences 
where the FitA dimer binds to are in bold and boxed. Arrows labelled A9 and A1 
mark where transposons were inserted in the mutagenesis screen. Figure adapted 
from (Hopper et al., 2000). Nucleotide sequence accession number is AF200716 
(Hopper et al., 2000). 
The rates of intracellular replication of the A9 mutant (N. gonorrhoeae ΔfitAB) and 
of N. gonorrhoeae WT were measured. N. gonorrhoeae ΔfitAB replicated faster 
than N. gonorrhoeae WT (Hopper et al., 2000). When expression of fitAB was 
knocked out, the rate of both transcytosis and intracellular replication were 
increased suggesting a link between replication inside epithelial cells and transport 
across the epithelial monolayer (Hopper et al., 2000). Extracellular growth 
remained the same between N. gonorrhoeae WT and ΔfitAB strains indicating 
FitAB is important for replication within epithelial cells but does not affect growth 
in media (Hopper et al., 2000). No further analysis was carried out to determine the 
mechanism(s) of growth regulation by FitAB (Hopper et al., 2000). Following this 
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discovery, FitAB was identified as a Type II VapBC TA system based on genetic 
and structural analysis (Arcus et al., 2011; Mattison et al., 2006).  
The fitAB operon is made up of the fitA and fitB loci with a one-base pair overlap 
in the stop codon of fitA and the start codon of fitB (Figure 1-4) (Hopper et al., 
2000). This overlap is typical of TA operons which are translationally coupled 
(Mattison et al., 2006; Wilbur et al., 2005). The unstable antitoxin, FitA, binds to 
the stable toxin, FitB, to form an inert FitAB complex (Figure 1-5). FitB has a 
C-terminal PIN-domain, typical of VapBC toxins (Arcus et al., 2011; Mattison et 
al., 2006). Conserved residues, Asp5, Glu42, Asp104, and Asp122, form a positively 
charged active site which binds a Mg2+ ion (Figure 1-5) (Mattison et al., 2006). 
When in the FitAB complex, FitA binds into the substrate binding pocket of FitB 
with a C-terminal α-helix, positioning a positively charged arginine residue (Arg68) 
into the active site of FitB to neutralise the pocket and inhibit Mg2+-dependent 
activity of FitB (Figure 1-5)(Mattison et al., 2006). 
 
 
Figure 1-5. Ribbon and surface diagram of FitA binding to FitB with close up of FitB 
active site. (a) Ribbon diagram of FitA (red) binding to FitB (blue & grey surface). (b) 
View of the four highly conserved residues in the active site of FitB showing placement 
of Arg68 (pink) from FitA. Residues are labelled with the three letter code and position 
in the amino acid sequence. When FitA is absent, the four conserved amino acids 
coordinate an Mg2+ ion. Image created in PyMOL using PDB file 2BSQ. 
FitAB auto-regulates transcription by binding to promoter DNA of the fitAB operon. 
FitA has an N-terminal DNA binding RHH domain made up of a β-strand and two 
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α-helices (Mattison et al., 2006). The β-strand is involved in recognising the 
inverted repeat sequence TGCTATCA-N12-TGATAGCA, while the two α-helices 
contribute to FitA homodimer formation, important for binding into the major 
groove of DNA (Figure 1-6) with high affinity to ensure tight regulation of 
transcription (Mattison et al., 2006; Wilbur et al., 2005). It is hypothesised that 
FitAB is bound to DNA in the extracellular environment but when the bacteria 
invade epithelial cells the complex is released, resulting in dissociation of the 
complex and transcription of the operon (Mattison et al., 2006). 
 
Figure 1-6. Ribbon and surface diagram of FitAB bound to DNA. FitA dimers (red) 
bind to major grooves in the 36-base pair double-stranded DNA molecule. FitB (blue) 
bound to FitA form two dimers either side of the DNA. Structure solved by x-ray 
crystallography (Mattison et al., 2006). PDB file 2BSQ. 
The mechanism of growth regulation by FitAB and its role in N. gonorrhoeae 
infection are currently unknown. We hypothesise a general mode of action based 
on the current structural knowledge and understanding of other VapBC TA systems 
(Arcus et al., 2011; Mattison et al., 2006; Wilbur et al., 2005; Winther & Gerdes, 
2012). When N. gonorrhoeae invade epithelial cells, FitAB dissociates from the 
operon which promotes overexpression of fitAB. Conditions of cellular stress or 
proteases degrade FitA, releasing active FitB which likely cleaves mRNA 
transcripts to disrupt protein synthesis, causing growth to slow down or cease, and 
subsequently slowing transepithelial trafficking.  
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1.6 Research Objectives 
The aim of my master’s research was to characterise the FitAB TA system in 
N. gonorrhoeae and investigate its role in intracellular replication. The following 
objectives were set to fulfil this aim: 
1) Determine if FitB has ribonuclease activity and characterise the specificity 
of this activity using biochemical assays.  
2) Expand on the intracellular replication experiment performed by Hopper et 
al. (2000) to characterise growth of N. gonorrhoeae wild-type and fitAB 
gene deletion strains, within human epithelial cells.  
3) Extract RNA from N. gonorrhoeae wild-type and fitAB gene deletion strains 
at various time-points during an intracellular replication assay (as in (2)) for 
RNA-seq. By analysing the transcriptomes of bacteria grown intracellularly, 






2 Chapter Two 
Ribonuclease Activity of FitB 
2.1 Introduction 
FitAB is a VapBC toxin-antitoxin (TA) system (Arcus et al., 2011; Mattison et al., 
2006) that has been implicated in the cellular trafficking of N. gonorrhoeae (Hopper 
et al., 2000). The TA system is comprised of two proteins; an antitoxin, FitA, and 
a toxin, FitB (Mattison et al., 2006). As with all VapC toxins, FitB has a PIN-
domain like fold and possesses an acidic pocket with four residues, Asp5, Glu42, 
Asp104, and Asp122, which are highly conserved throughout PIN-domain proteins 
(Arcus et al., 2011; Mattison et al., 2006). PIN-domains generally show metal-
dependent ribonuclease activity in prokaryotes (Arcus et al., 2004; Clissold & 
Ponting, 2000) and many VapC proteins have been characterised as having 
sequence-specific ribonuclease activity (McKenzie et al., 2012b; Sharrock et al., 
2018; Winther & Gerdes, 2011). We, therefore, predict FitB has ribonuclease 
activity. 
Biochemical characterisation of VapC proteins have shown VapC cleaves RNA 
molecules at specific cut sites, unique to each VapC (McKenzie et al., 2012b; 
Sharrock et al., 2018; Winther & Gerdes, 2011). The target sequence of VapC 
proteins from M. tuberculosis, M. smegamtis and P. aerophilum has been 
characterised using a method developed in our lab (McKenzie et al., 2012a). This 
method incorporates the pentaprobe system and MALDI-TOF MS (Figure 2-1) 
(McKenzie et al., 2012a; McKenzie et al., 2012b; Sharrock et al., 2018). Generally, 
the ribonuclease activity of each VapC protein was screened against seven RNA 
pentaprobes that encompass all possible combinations of five bases. Shorter RNA 
oligonucleotides (oligos) were designed from cut pentaprobes and used for further 
ribonuclease testing. The target sequence was identified by MALDI-TOF MS 
analysis of the cut RNA oligos (McKenzie et al., 2012a).  
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Figure 2-1. Schematic diagram of pentaprobe activity screens, sequence specificity 
and kinetic analysis. Ribonuclease activity of VapC is tested using pentaprobes and 
shorter oligonucleotides are designed based on the cut (ticked) pentaprobe. The cut 
sites are determined by MALDI-TOF MS. Kinetic parameters of VapC are 
determined by fluorometric analysis. Diagram retrieved from (McKenzie et al., 
2012a). 
Early attempts to characterise activity of FitB failed to demonstrate any nuclease 
activity (Mattison et al., 2006). Initially, activity assays were performed using the 
FitAB complex with single and double stranded RNA and DNA substrates 
(Mattison et al., 2006). This, unsurprisingly, resulted in no nuclease activity as FitB 
would have been inhibited by FitA. Assays performed using FitB on its own were 
limited to a short, 36 base-pair, double-stranded DNA substrate, also resulting in 
no nucleic acid cleavage (Mattison et al., 2006). Given the current understanding 
of VapC proteins, we assume no nuclease activity was identified in these 
experiments as VapC proteins act on RNA substrates rather than DNA (Arcus et al., 
2011; McKenzie et al., 2012a; Ramage et al., 2009). 
This chapter characterises FitB ribonuclease activity by way of biochemical activity 
assays, using methods previously established in our lab (McKenzie et al., 2012a).  
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2.1 Materials & Methods 
2.1.1 Methods for cloning fitAB and fitB 
FitAB and FitB genes were cloned into expression vectors based on past 
publications (Mattison et al., 2006; Wilbur et al., 2005). The fitAB gene construct 
was codon optimised for E. coli and synthesised by GeneArt (ThermoFisher) for 
cloning into plasmid pET28b-PstI with PstI and XhoI restriction cut sites for 
expression with a C-terminal His-tag.  
FitAB was PCR amplified using the fitA-PstI forward primer 
(CTAGCTGCAGATGGCTAGCGTTGT) and fitB-XhoI reverse primer 
(CAGTACTCGAGATCATGCCACGGATTA), and fitB PCR amplified using the 
fitB-PstI forward primer (TTTACTGCAGATGATTCTGCTGGATAC) and the 
fitB-XhoI reverse primer above. PCR products and pET28b-pstI were digested with 
PstI-HF and XhoI restriction enzymes (NEB) according to manufacturer’s 
instructions. Restriction enzyme digests were purified using the MoBio Ultraclean 
DNA Purification kit according to manufacturer’s instructions. Purified DNA from 
each reaction was quantified by NanoDropTM. Ligation reactions were set up in a 
3:1 insert:plasmid molar ratio using T4 DNA ligase (NEB) according to 
manufacturer’s instructions. Ligation reactions were incubate at 20 °C for 2 hours 
then placed at 4 °C overnight.  
Each ligation reaction (fitAB and fitB) was transformed into chemically competent 
E. coli DH5α and positive transformants selected by growth on LB agar plates 
supplemented with 50 µg ml-1 kanamycin incubated at 37 °C overnight. Plasmids 
were extracted from transformed colonies using a Qiagen Miniprep kit. Correct 
insertion of fitAB and fitB genes was confirmed by sequencing using T7 forward 
and reverse primers. Sequenced plasmids were then transformed into chemically 
competent E. coli BL21 (DE3) cells. Glycerol stocks of E. coli BL21 pET28b-pstI 
fitAB and E. coli BL21 pET28b-pstI fitB were stored at -80 °C. 
2.1.2 FitB large scale expression cultures  
The E. coli BL21 (DE3) pET28b-pstI fitB glycerol stock was thawed on ice and was 
streaked onto LB agar supplemented with 50 µg ml-1 kanamycin and incubated at 
37 °C overnight. A single colony was taken from the plate and added to 10 ml LB 
broth supplemented with 50 µg ml-1 kanamycin. Cultures were incubated at 37 °C, 
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180 rpm overnight. These cultures were then transferred to 1 L LB broth with 50 
µg ml-1 kanamycin in a 2 L baffled flask. These were incubated at 37 °C, 200 rpm 
for approximately 3 hours until the cultures reached an OD600 of approximately 0.5 
to 0.6. Protein expression was induced by addition of 1 ml 0.75 M IPTG (final 
concentration 0.75 mM). The expression culture was then incubated at 22 °C, 
200 rpm for 14 hours.  
Cells were harvested by centrifugation at 4,600 g for 20 min at 4 °C and the 
supernatant removed. The cell pellet was resuspended in 15 ml Lysis buffer 
(50 mM NaHPO4 pH 7.4, 200 mM NaCl, 20 mM Imidazole) and pooled in a 50 ml 
falcon tube. Resuspended cells were centrifuged at 4,600 g for 20 min at 4 °C and 
the supernatant was removed. The cell pellet was stored at -80 °C until purification. 
2.1.3 FitAB large scale expression cultures 
FitAB expression cultures were set up as per the protocol for FitB (section 2.1.2) 
except 2 L expression cultures were incubated at 37 °C, 200 rpm for 3 hours 
following IPTG induction. 
2.1.4 Methods for protein analysis 
2.1.4.1 SDS-PAGE 
SDS-PAGE gels consisted of a resolving gel (15% acrylamide) and a stacking gel 
(5% acrylamide). Gels were poured in a Hoeffer five gel multi-gel caster. The 
resolving gel solution (Table 2-1) was poured into the gel plates, approximately 
2 cm from the top. Two millilitres of isopropanol was gently pipetted on top of the 
resolving gel and the gel was left to set at room temperature (RT) for approximately 
40 min. Once set, the isopropanol was decanted and the stacking gel (Table 2-1) 
poured on top of the resolving gel. Gel combs were added to each gel and the stacker 
gel was left to set as above.  
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Table 2-1. Recipe for 15% SDS-PAGE gels (to make five mini-gels). 
 Resolving gel (15%) Stacking gel (5%) 
Water 7.05 ml 8.5 ml 
30% Acrylamide 15 ml 2.125 ml 
Resolving Buffer  
(1.5 M Tris, pH 8.8) 
7.5 ml - 
Stacking Buffer  
(1.0 M Tris, pH 6.8) 
- 1.6 ml 
10% SDS 300 µl 125 µl 
10% APS 150 µl 63 µl 
TEMED 15 µl 6.3 µl 
 
To prepare samples for gel loading, 5 µl 4 X protein loading dye (250 mM Tris-
HCl, pH 6.8, 20% Glycerol, 4% SDS, 10% mercaptoethanol, 0.025% bromophenol 
blue) was added to 15 µl of each sample. When preparing concentrated samples 
(e.g. cell pellet or cell lysate) 3 µl sample was added to 12 µl of the appropriate 
lysis buffer and then 5 µl 4 X loading dye added. Samples were then heated to 95 °C 
for 5 min. Samples and 10 µl Precision Plus Protein Standard (BioRad) were loaded 
onto the gel and run in 1 X Tris-Glycine SDS Running Buffer (25 mM Tris, 
250 mM Glycine, 0.1% SDS) at 70 V until samples entered the resolving gel. 
Voltage was then increased to 100 V and ran until samples reached the end of the 
resolving gel.  
Gels were post-stained with Fairbanks A Staining Solution (0.05% Coomassie Blue, 
25% isopropanol, 10% acetic acid). Solution was poured over protein gels and 
brought to the boil by heating for 30 sec in the microwave followed by shaking for 
5 min at RT. To remove background staining, gels were destained with Fairbanks 
destaining solution (10% acetic acid) with the same heating and shaking procedure 
as above. Gels were imaged using an iBright imager (Invitrogen). 
2.1.4.2 Native-PAGE 
Native-PAGE gels were poured as for SDS-PAGE gels in section 2.1.4.1 above 
except with 12% acrylamide in the resolving gel and without the addition of SDS. 
Samples were prepared by adding 4 µl 5 X native loading dye (300 mM Tris-HCl, 
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pH 6.8, 50% Glycerol, 0.05% bromophenol blue) to 16 µl of each sample. Samples 
and 10 µl Precision Plus Protein Standard (BioRad) were loaded onto the gel and 
run in 1 X Tris-Glycine Running Buffer (25 mM Tris, 250 mM Glycine) at 70 V 
until samples entered the resolving gel. Voltage was then increased to 100 V and 
ran until samples reached the end of the resolving gel. Gels were stained and 
visualised as above in section 2.1.4.1. 
2.1.5 Optimisation of FitB purification  
FitB was purified using immobilized metal affinity chromatography (IMAC). Three 
different conditions were trialled to achieve FitB protein that was stable following 
purification. 
2.1.5.1 IMAC purification with 1% Triton X-100 
Triton X-100 was added to the Lysis buffer (50 mM NaHPO4 pH 7.4, 200 mM NaCl, 
20 mM Imidazole) and the Elution buffer (50 mM NaHPO4 pH 7.4, 200 mM NaCl, 
1 M Imidazole) to a final concentration of 1% Triton X-100.  
A FitB expression culture cell pellet (see Section 2.1.2) was thawed at RT. The cell 
pellet was resuspended in 25 ml Lysis Buffer including Triton X-100 and sonicated 
on ice using a Misonix sonicator with a 5-50 ml microtip, setting 4, for 2.5 min in 
30 sec intervals with 30 sec on ice in between intervals to keep sample temperature 
low. The cell lysate was centrifuged at 13,000 g for 20 min at 4°C to separate 
soluble and insoluble fractions. The supernatant (soluble fraction) was filtered 
through 1.2 µm, 0.45 µm, and 0.2 µm Minisart filters. 
The filtered supernatant was loaded onto a pre-equilibrated 5 ml Ni HisTrap HP 
column (GE Healthcare Life Science) on a BioRad NGC system using the sample 
pump at a flow rate of 1 ml min-1. The column was washed with 15 ml Lysis Buffer 
with Triton X-100 at a flow rate of 2 ml min-1 to remove any unbound proteins. 
These were collected for analysis. Bound proteins were eluted into collection tubes 
by running a gradient of 0% to 50% of the Elution buffer with Triton X-100 over 
50 ml, at a flow rate of 2 ml min-1. The eluted fractions (peak fractions) 
corresponding to a peak on the resulting 280 nm chromatogram were collected and 
stored on ice. Proteins that were unbound and eluted from the column during the 
wash step (flow through) and those eluted with elution buffer (peak fractions) were 
assessed by SDS-PAGE (section 2.1.4.1) and Native-PAGE (section 2.1.4.2). 
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2.1.5.2 IMAC purification with 5% glycerol 
A FitB cell pellet was prepared for purification as in section 2.1.5.1 except glycerol 
was added to the Lysis and Elution buffers to a final concentration of 5%. IMAC 
purification was carried out as above (section 2.1.5.1) but an AKTA Basic (GE) 
chromatography system was used instead of the BioRad NGC system. Samples 
were analysed by SDS-PAGE (section 2.1.4.1) and Native-PAGE (section 2.1.4.2). 
2.1.5.3 IMAC purification on ice 
A FitB cell pellet was prepared and purified as in section 2.1.5.1, except no 
Triton X-100 was added to buffers. IMAC purification was performed using a 
BioRad NGC system (as in section 2.1.5.1) with fraction collection tubes situated 
on ice. The peak fractions were analysed by SDS-PAGE (section 2.1.4.1) and 
Native-PAGE (section 2.1.4.2) immediately following elution from the nickel 
column. When used in ribonuclease activity assays, eluted protein was taken 
immediately following elution and added to the reactions.  
2.1.6 IMAC purification of FitAB 
FitAB was Ni purified as for FitB (section 2.1.5.1) except no Triton X-100 was 
added to the buffers. 
2.1.7 Expression and purification of CysE  
CysE was expressed and purified by Keely Oldham as for FitB (refer to section 
2.1.2 and 2.1.5.3).  
2.1.8 Methods used for FitB mutagenesis  
Two mutants of fitB were designed with point mutations in the PIN-domain active 
site. The mutation in one mutant was aspartate (position 104) to asparagine, the 
other was glutamate (position 42) to glutamine. Two different PCR based 
mutagenesis methods were performed to introduce the desired mutation into the fitB 
plasmid. 
2.1.8.1 Two-halves mutagenesis method 
Mutagenesis by two-halves involves creating each half of the gene from the plasmid 
individually before annealing these halves together to generate the full mutated 
gene, which is inserted back into the plasmid. The halves are generated by two PCR 
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reactions, one using the forward mutant primer with the reverse fitB primer, the 
other using the reverse mutant primer and the forward fitB primer.  
The mutant primers were designed for the E. coli optimised version of fitB with the 
mutated codon in the centre of each primer (Table 2-2) using the Quikchange 
Primer Design software (Agilent Technologies, USA).  
Table 2-2. Primer sequences used to generate fitB D104N mutant and fitB E42Q 
mutant using the two-halves mutagenesis method. The mutated codons are bold. 
















The PCR reactions to generate two halves were set up using HOT FIREPol® DNA 
polymerase Blend Master mix with the fitB pET28b-pstI plasmid as the DNA 
template. Reactions were set up as in Table 2-3 with the following primer 
combinations: 
fitB D104N forward: fitB PstI forward and fitB D104N reverse primers 
fitB D104N reverse: fitB D104N forward and fitB XhoI reverse primers 
fitB E42Q forward: fitB PstI forward and fitB E42Q reverse primers 
fitB E42Q reverse: fitB E42Q forward and fitB XhoI reverse primers 
PCR reactions were performed in replicates of four with one negative control in 
which the DNA template was omitted. The PCR cycling protocol was based on 
HOT FIREPol® DNA polymerase manufacturer recommendations (Table 2-4). 
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Table 2-3. Two-halves mutagenesis PCR reaction conditions. 
Component Concentration 
5 X Master Mix 1 X 
10 µM forward primer 0.3 µM 
10 µM reverse primer 0.3 µM 
Plasmid DNA template 0.6 ng 
 
Table 2-4. Two-halves mutagenesis PCR cycling protocol. 
PCR Cycles Step Temperature Time (min:sec) 
1 Initial denaturation 95°C 15:00 
30 
Denature 95°C 0:20 
Anneal 57°C 0:30 
Extend 72°C 1:00 
1 Final extension 72°C 10:00 
 
Following PCR amplification, the 20 µl reactions were loaded onto a 1% agarose 
gel pre-stained with 1 X SYBR Safe DNA gel stain (Invitrogen). Agarose gels were 
run at 100 V for 40 min. Gels were visualised using a blue light box and PCR 
products of the correct size were cut out of the gel and purified using the MoBio 
Ultraclean 15 DNA purification kit according to manufacturer’s instructions.  
Purified PCR products were used in a subsequent PCR reaction to generate the full-
length gene. A PCR reaction was set up for each mutant using two corresponding 
half products as the DNA template. Each PCR product was added in a 1:1 molar 
ratio in the combination as follows: 
fitB D104N reaction: fitB D104N forward with fitB D104N reverse PCR 
products 
fitB E42Q reaction: fitB E42Q forward with fitB E42Q reverse PCR products  
The reactions were prepared as in Table 2-5 in replicates of four and one negative 
control with no DNA template. PCR reactions were performed as for the first round 
of PCR above (Table 2-4). 
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Table 2-5. Two-halves mutagenesis PCR reaction conditions using the forward and 
reverse PCR products as DNA templates.  
Component Concentration 
5 X Master Mix 1X 
10 mM forward primer 0.3 mM 
10 mM reverse primer 0.3 mM 
Forward PCR product  5 ng 
Reverse PCR product 5 ng 
 
The four replicate PCR reactions for each mutant were pooled (total volume of 
80 µl) and loaded on a 1% agarose gels pre-stained with 1 X SYBR Safe DNA gel 
stain (Invitrogen). Gels were run at 100 V for 40 min. PCR products of the correct 
size were cut from the gel and purified using the MoBio UltraClean 15 DNA 
purification kit and resuspended in 20 µl nuclease free water.  
A restriction digest was carried out on each PCR product using the restriction 
enzymes PstI-HF and XhoI in CutSmart buffer (NEB). All reaction components 
(Table 2-6) were combined and incubated at 37 °C, 300 rpm for 2 hours. The 
restriction enzyme digest reactions were purified using the MoBio UltraClean 15 
DNA purification kit. 
Table 2-6. Composition of double restriction digest reaction. 
Component Volume (50 µl reaction) 
XhoI 1 µl 
PstI-HF 1 µl 
DNA 1 µg 
10 X CutSmart buffer 5 µl 
Water to 50 µl 
 
The digested PCR products were ligated using T4 DNA ligase (NEB) into pET28b-
PstI, in a 3:1 insert:plasmid molar ratio, following the T4 DNA ligation (NEB) 
protocol. All components were combined (Table 2-7) and incubated at 4 °C for 48 
hours. To transform the plasmids into chemically competent E. coli DH5α, 10 µl 
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ligation reaction was added to 100 µl chemically competent E. coli DH5α and 
incubated on ice for 30 min. The bacteria were heat shocked at 42 °C for 45 secs 
and then placed on ice for 2 min. One millilitre of LB broth was added and 
incubated at 37 °C, shaking at 300 rpm, for 1 hour. One hundred microliters of 
bacteria were spread onto a LB agar plate with 50 µg ml-1 kanamycin and incubated 
overnight at 37 °C. Colonies from the plates were screened for successful 
transformation by colony PCR using T7 forward and reverse primers. A PCR 
reaction was set up for each colony (Table 2-8) and carried out using an Eppendorf 
PCR machine (Table 2-9) then assessed on a 1% TAE agarose gel as described 
previously. The colonies that contained the plasmid with the desired gene insert 
were grown in 5 ml LB broth with 50 µg ml-1 kanamycin overnight at 37 °C. The 
plasmid was extracted using the Qiagen Miniprep kit as per manufacturer’s 
instructions and sequenced by the Massey Genome Sequencing Service with T7 
forward and reverse primers.  
Table 2-7. Ligation reaction of full length gene PCR product and pET28b-pstI. 
Component  Volume (20 µl reaction) 
10 X T4 DNA ligase buffer 2 µl 
pET28b-PstI plasmid 1.1 µl 
fitB D104N PCR product 0.84 µl 
T4 DNA ligase 1 µl 
Water to 20 µl 
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Table 2-8. Colony PCR conditions. 
Components Volume (25 µl reaction) Final concentration 
10 X PCR buffer 2.5 µl 1 X 
50 mM MgCl2 0.75 1.5 mM 
10 mM dNTPs 0.5 0.2 mM 
10 µM T7 forward primer 1.25 µl 0.5 µM 
10 µM T7 reverse primer 1.25 µl 0.5 µM 
Taq polymerase 0.1 µl  
Water to 25 µl - 
 
Table 2-9. Colony PCR cycling protocol. 
PCR Cycles Step Temperature Time (min:sec) 
1 Initial denaturation 95°C 15:00 
30 
Denature 94°C 0:45 
Anneal 55°C 0:30 
Extend 72°C 3:00 
1 Final extension 72°C 10:00 
 
2.1.8.2 Site-directed mutagenesis method 
The site-directed mutagenesis method introduces a point mutation directly into 
circular plasmid DNA. Template DNA is removed by DpnI digestion and the 
mutated plasmid is directly transformed into E. coli. 
For this method of mutagenesis, Platinum SuperfiTM DNA polymerase (Invitrogen) 
was used and the mutant primers were designed differently than those used for 
two-halves mutagenesis method above (section 2.1.8.1). Mutant primers were 
designed using Geneious (Biomatters) with a 21-nucleotide complementary region 
containing the targeted mutation, followed by nine non-overlapping bases at the 3’-
terminus (Table 2-10).  
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The primer annealing temperatures were calculated using the Tm calculator online, 
specifically designed for site-directed mutagenesis using Platinum SuperfiTM DNA 
polymerase (thermofisher.com/tmcalculator). The site-directed mutagenesis PCR 
reaction was carried out following the manufacturer’s protocol (Table 2-11 and 
Table 2-12) using an Eppendorf PCR machine and fitB pET28b-pstI plasmid as the 
DNA template. 
Table 2-10. Primer sequences for site-directed mutagenesis of fitB. The non-
overlapping region is underlined and the mutated codon is in bold. 
Name Sequence (5’-3’) 
fitB E42Q forward ACCGTTGCACAGCTGCGTCTGGGTGTTGCA 
fitB E42Q reverse CAGACGCAGCTGTGCAACGGTAATTGCGCT 
 
Table 2-11. Site-directed mutagenesis PCR reaction. 
Component 
Volume  
(50 µl reaction) 
Final 
concentration 
Nuclease free water To 50 µl - 
5 X Superfi Buffer 10 µl 1X 
dNTP mix (10 mM each) 1 µl 0.2 mM each 
10 µM forward primer 2.5 µl 0.5 µM 
10 µM reverse primer 2.5 µl 0.5 µM 
Plasmid DNA template 10 ng 10 ng 
Platinum SuperFi DNA Polymerase 
(2 U µl-1) 
0.5 µl 0.02 U µl-1 
  
Chapter Two: Ribonuclease Activity of FitB 
30 
















98 0:30 98 0:30 
30 
Denature 98 0:10 98 0:10 
Anneal 67.7 0:10 72 0:10 




72 5:00 72 5:00 
 
Upon completion of the PCR reaction, template DNA was removed by addition of 
1.5 µl DpnI (NEB) and incubated at 37 °C for 1 hour. DpnI was inactivated by 
heating the reaction to 80 °C for 20 min. Five microliters of the PCR product was 
directly transformed into chemically competent E. coli DH5α following the same 
protocol as described above in section 2.1.8.1. Colonies were selected from a LB 
agar plate including 50 µg ml-1 kanamycin and used to inoculate 5 ml LB broth with 
50 µg ml-1 kanamycin then incubated overnight at 37 °C, shaking at 180 rpm. The 
plasmid was extracted using the Qiagen Miniprep kit as per manufacturer’s 
instructions and sequenced by the Massey Genome Sequencing Service with T7 
forward and reverse primers.  
2.1.9 The Pentaprobe System 
2.1.9.1 Preparation of DNA pentaprobes 
The pentaprobe system was obtained from Joel McKay, School of Molecular 
Bioscience, University of Sydney. The system consists of 12 plasmids each 
containing a pentaprobe strand in the forward or reverse direction. Pentaprobes in 
the forward direction are termed 922, 923, 924, 925, 926, and 927, and the 
corresponding complementary strands are termed 928, 929, 930, 931, 932, and 933, 
respectively.  
Pentaprobe inserts 922, 923, 924, 925, 926, 927 and 932 (Appendix B.1.) were PCR 
amplified using the Pfx® DNA polymerase system (Invitrogen) with forward and 
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reverse primers flanking the pentaprobe insert and including the T7 promoter in 
pcDNA3. See Table 2-13 and Table 2-14 for reaction concentrations and conditions. 
Table 2-13. Reaction concentrations for Platinum Pfx® PCR reaction. 
Component Concentration 
Pfx amplification buffer 1 X 
Deoxynucleotide mix  
(dATP, dCTP, dTTp & dATP) 
0.3 mM 
MgSO4 1 mM 
Enhancer solution 1 X 
Platinum Pfx® DNA polymerase 2 U 
Forward & reverse primers 0.2 µM 
Template DNA 20-120 ng 
 
Table 2-14. Platinum Pfx® PCR reaction cycling conditions for amplification of 
pentaprobe inserts. 
PCR Cycles Step Temperature Time (min:sec) 
1 Initial denaturation 94°C 2:00 
30 
Denature 94°C 0:15 
Anneal 55°C 0:30 
Extend 68°C 0:45 
1 Final extension 68°C 7:00 
 
2.1.9.2 Transcription of Pentaprobe RNA transcripts 
The RNA Pentaprobes (922, 923, 924, 925, 926, 927, 932) were transcribed from 
the pentaprobe PCR products (Section 2.1.9.1 above) using T7 MEGAscript® kit 
(Ambion) according to manufacturer’s instructions (Table 2-15). Transcription 
reactions were incubated at 37 °C for 2 hours followed by the addition of 1 µl 
TURBO DNase to remove template DNA and further incubated at 37 °C for 15 min. 
RNA was precipitated by sodium acetate and ethanol precipitation (section 2.1.10.1 
below) RNA was resuspended in 30 µl nuclease free H2O and concentration 
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determined by NanoDropTM. A working stock was made in nuclease-free water to 
a final concentration of 1 mg ml-1 and stored at -80 °C.  
Table 2-15. Reaction composition for the transcription reaction of Pentaprobes using 
the T7 Megascript kit. 
Component Volume (20 µl reaction) 
Water, nuclease free to 20 µl 
rNTP mix (10 mM each) 8 µl 
10 X reaction buffer 2 µl 
DNA template 200 ng 
T7 transcriptase enzyme mix 2 µl 
 
2.1.10 Ribonuclease activity screens 
2.1.10.1 Sodium acetate and ethanol precipitation 
To purify RNA from activity assays, 1/10th of the volume of 3 M sodium acetate, 
pH 5.2, was added to the sample, followed by 2.5 volumes of ice-cold 200 proof 
ethanol. Samples were mixed gently by inverting several times then incubated 
at -20 °C overnight. Following incubation, samples were centrifuged at 13,000 g 
for 15 min at 4 °C to pellet the RNA. All supernatant was removed and the pellet 
washed with 800 µl 70% ethanol. Samples were centrifuged at 13,000 g for 10 min 
at 4 °C. All traces of ethanol were removed and the RNA pellet was air dried for 
5 min before being resuspended in 10 - 20 µl nuclease-free water.  
2.1.10.2 Ribonuclease activity assays with pentaprobe RNA substrates 
Ribonuclease activity assays using pentaprobe RNA transcripts were set up in a 5 X 
assay buffer (50 mM NaHPO4 pH 7.4, 200mM NaCl, 25 mM MgCl2) with 
1 mg ml-1 (20.2 pmol) Pentaprobe RNA. For each Pentaprobe RNA transcript tested, 
five reactions were set up:  
(i) RNA only 
(ii) addition of FitB 
(iii) addition of FitB and 10 mM EDTA 
(iv) addition of FitAB 
(v) addition of CysE 
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All assays were prepared on ice with 5 X assay buffer, water and RNA (Table 2-16). 
FitAB was purified (section 2.1.6) and added to reaction iv, CysE was purified 
(section 2.1.7) and added to reaction v. FitB was purified (section 2.1.5.3) and 
added to reaction ii once all other reactions had been prepared to avoid degradation 
of FitB during the assay. 
In preliminary assays, FitB activity was evaluated over a time course by stopping 
reactions by the addition of 10 µl 2 X formamide RNA loading dye after 5, 15 and 
30 min. RNA only and EDTA control reactions were stopped after 30 min. 
Reactions were then stored at -20 °C. In subsequent assays, all reactions were 
stopped after 30 min. Ribonuclease activity was evaluated by urea-denaturing 
polyacrylamide gel electrophoresis (urea-PAGE) (section 2.1.10.3). 








5 X Assay Buffer 2 µl 2 µl - 2 µl 2 µl 
5 X Assay Buffer + 
50 mM EDTA 
- - 2 µl - - 
Water to 10 µl to 10 µl to 10 µl to 10 µl to 10 µl 
Pentaprobe RNA  
(1 mg ml-1 = 20.2 pmol) 
2 µl 2 µl 2 µl 2 µl 2 µl 
FitB protein 
(approx. 0.10 mg ml-1  
= 6.1 pmol µl-1) 
- 6 µl.  6 µl - - 
FitAB protein 
(0.151 mg ml-1  
= 6.09 pmol µl-1) 
- - - 6 µl - 
CysE protein 
(1.425 mg ml-1  
= 44.12 pmol µl-1) 
- - - - 0.6 µl 
 
2.1.10.3 Urea-denaturing polyacrylamide gel electrophoresis. 
Ten percent urea-PAGE gels were made fresh (Table 2-17) with ten-well combs. 
The PAGE gel solution (8 M urea, 1 X TBE, 10% acrylamide and water) was heated 
to 55 °C with a stirring rod to dissolve all the urea before APS and TEMED were 
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added. Gels were poured into a Hoeffer multi gel-caster and left to set at RT for 
approximately 1 hour. Gels were pre-run in 1 X TBE buffer for 30 min at 100 V. 
Wells were flushed with 1 X TBE to remove any remaining urea. Ribonuclease 
activity assay samples were thawed on ice then heated to 75 °C for 5 min and 
returned to ice. Low range ssRNA ladder (NEB) was loaded (0.5 µg) on the gel 
alongside 20 µl of each sample. Gels were run at 150 V for approximately 1 hour. 
Gels were post-stained with 1 X SYBR Safe DNA gel stain (Invitrogen) in 1 X TBE 
Buffer and visualised using an iBright imager (Invitrogen). Band sizes were 
determined by comparison with the low range ssRNA ladder (NEB). 
Table 2-17. Composition of 10% urea-PAGE gels (to make five mini-gels). 




Urea 22 g 8 M 
10 x TBE 5 ml 1 X 
30% Acrylamide 16.7 ml 10 % 
Diethyl pyruvate carbonate (DEPC) 
treated water 
to 50 ml - 
10% APS 150 µl 0.3% 
TEMED 30 µl  
 
2.1.10.4 Ribonuclease activity assays with oligonucleotides 
Short RNA oligos, 20 - 30 nucleotides (nt) long, were designed in Geneious 
(Biomatters) based on the 923 Pentaprobe sequence. The oligos were designed to 
have ten overlapping nucleotides at each end to ensure all sequence combinations 
from pentaprobe 923 were still present. They were labelled ‘Oligo 1-5’ (Appendix 
B.3.) and ordered from IDT.  
To screen activity of FitB against these oligos, assays were prepared with 5 X Assay 
Buffer (as in section 2.1.10.2 above) and 1 mg ml-1 (100 pmol) each RNA oligo. 
For each RNA oligo tested, three reactions were set up:  
(i) RNA only 
(ii) addition of FitB 
(iii) addition of FitB and 10 mM EDTA 
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As with the Pentaprobe assays above, all assays were set up on ice to a final volume 
of 10 µl with nuclease free water. Reactions were incubated at 37 °C for 30 min and 
stopped by the addition of 10 µl 2 X formamide RNA loading dye. Reactions were 
analysed by urea-PAGE as above (section 2.1.10.3) except 15% urea-denaturing 
gels were used by adding 25 ml of 30% acrylamide instead of 16.7 ml when 
preparing the gels.  
2.1.11 High Performance Liquid Chromatography and Mass 
Spectrometry 
We worked in consultation with Grant Smolenski at MS3 Solutions to develop a 
new method using High Performance Liquid Chromatography (HPLC) followed by 
MS to deduce cut site(s) of the RNA pentaprobes. RNA pentaprobes cut by FitB 
were analysed by this approach. 
2.1.11.1 Preparation of RNA for HPLC-MS 
To prepare assay reactions for HPLC-MS, modifications were made to the 
purification of FitB and the pentaprobe ribonuclease activity assays. FitB was 
purified as in section 2.1.5.3 except a Tris Lysis buffer (50 mM Tris pH 7.4, 200 
mM NaCl, 20 mM Imidazole) and a Tris Elution buffer (50 mM Tris pH 7.4, 200 
mM NaCl, 1 M Imidazole) were used. The pentaprobe assay buffer was changed to 
a 5 X ammonium phosphate buffer (50 mM NH4PO4 pH 7.4, 200mM NaCl, 25 mM 
MgCl2). The ribonuclease activity reactions were stopped with 4 µl 5 M ammonium 
acetate and 2 volumes of ice-cold 200 proof ethanol and stored at -20 °C overnight. 
Samples were centrifuged at 13,000 g for 20 min at 4 °C. The supernatant was 
removed and the RNA pellet washed with 70% ethanol and centrifuged for a further 
20 min as above. All traces of ethanol were removed and the RNA was resuspended 
in 10 µl nuclease-free water. All samples were stored at -80 °C until taken to MS3 
solutions for analysis. 
2.1.12 Reverse transcription and cDNA sequencing 
This method was developed for sequencing cut RNA pentaprobes from the 
ribonuclease activity assays to deduce the cut site(s) targeted by FitB. 
RNA was prepared for cDNA analysis in the same way as for HPLC-MS (section 
2.1.11.1). 
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2.1.12.1 Circularisation of RNA fragments 
The fragmented pentaprobes from each reaction were circularised using T4 RNA 
Ligase I (NEB) according to manufacturer’s instructions (Table 2-18). Reactions 
were incubated at 25 °C, shaking at 300 rpm for 1.5 hours and stopped by heat 
inactivation at 65 °C, shaking at 300 rpm for 15 min. RNA was precipitated by 
sodium acetate and ethanol precipitation (as in section 2.1.10.1) and resuspended in 
10 µl nuclease free H2O. 
Table 2-18. T4 RNA ligase reaction for circularisation of RNA. 
Component Volume (20 µl reaction) Final concentration 
10 X Reaction Buffer 2 µl 1 X 
RNA (1 µg) 10 µl  
T4 RNA Ligase 1 µl 10 units 
RNase Inhibitor (40 µ µl-1) 0.5 µl  
PEG8000 (50%) 4 µl 10% 
ATP (1 mM) 0.6 µl 30 µM 
Water to 20 µl  
 
2.1.12.2 First-strand cDNA synthesis. 
The circular RNA was used as a template to synthesise the first cDNA strand using 
qScript XLT cDNA Supermix (QuantaBio). The reaction was prepared on ice 
following manufacturer’s instructions (Table 2-19). All Components were 
combined and vortexed briefly to mix. The reaction was centrifuged for 3 sec before 
incubation at a series of temperatures: 25 °C for 5 min, 42 °C for 1 hour, 85 °C for 
5 min followed 4 °C indefinitely. The RNA:cDNA  hybrid was precipitated from 
the reaction via a sodium acetate and ethanol precipitation as in section 2.1.10.1and 
resuspended in 10 µl water.  
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Table 2-19. Q-script XLT cDNA Supermix reaction composition. 
Component 




qScript XLT cDNA Supermix 
(5 X) 
4 µl 1 X 
RNA 10 µl varies 
Water to 20 µl  
 
2.1.12.3 Second-strand cDNA synthesis. 
The second cDNA strand was generated by nick translation using the RNA:cDNA  
hybrid from the first-strand cDNA synthesis reaction. The 10 X Second-strand 
Buffer was composed of 10 X NEB-Buffer 2 (50 mM NaCl, 10 mM Tris-HCl, 10 
mM MgCl2, 1 mM DTT), 10 X T4 DNA Ligase Reaction Buffer (NEB) (50 mM 
Tris-HCl, 10 mM MgCl2, 10 mM DTT, 1 mM ATP) and 10 X RNase H Reaction 
Buffer (NEB) (75 mM KCl, 50 mM Tris-HCl, 3 mM MgCl2, 10 mM DTT) in a 
1:1:1 ratio. All the second strand reaction components (Table 2-20) were added in 
order to the RNA:cDNA  hybrid and vortexed gently to mix. The reaction was 
incubated at 16 °C for 2 hours then placed on ice before the addition of 25 µl 0.25 M 
sodium EDTA, pH 7.5. The cDNA was precipitated out of solution by adding 
ammonium acetate (final concentration of 1 M) and ethanol (final concentration 
75%) and incubating at -20 °C for 2 hours. The reaction was then centrifuged at 
13,000 g for 20 min at 4 °C to pellet cDNA and supernatant was removed. The 
pellet was resuspended in 20 µl NEB-buffer 2 and the cDNA concentration 
measured by NanoDropTM. 
  
Chapter Two: Ribonuclease Activity of FitB 
38 
Table 2-20. Composition of second-strand cDNA synthesis reaction. 
Component Concentration 
RNA:cDNA  hybrid 1 µg 
DEPC-treated water - 
10 mM dNTP mix 250 µM each (dATP, dCTP, dGTP, dTTP) 
10 X Second-strand Buffer 1 X 
E. coli DNA Pol I (NEB) 250 U ml-1 
E. coli RNase H (NEB) 8.5 U ml-1 
E. coli T4 DNA Ligase (NEB) 30 U ml-1 
 
2.1.12.4 Generation of blunt ends  
Blunt ends were generated on cDNA strands using DNA Polymerase I (DNA Pol 
I), Large (Klenow) Fragment (NEB). A mix of dNTPs, containing 33 µm dATP, 
dCTP, dGTP and dTTP, were added to cDNA followed by 1 unit of Klenow per µg 
cDNA. The reaction was incubated at 25 °C for 15 min and stopped by addition of 
EDTA to a final concentration of 10 mM and heating to 75 °C for 20 min. The 
cDNA was precipitated out of solution as before by addition of ammonium acetate 
(final concentration of 1 M) and ethanol (final concentration 75%) and incubation 
at -20 °C for 2 hours. The reaction was centrifuged at 13,000 g for 20 min at 4 °C 
to pellet the cDNA and all supernatant removed. The cDNA was resuspended in 
10 µl nuclease-free water. 
2.1.12.5 Sequence preparation 
The cDNA product with blunt ends was ligated into the pGEM®-T Easy Vector 
(Promega) as per the manufacturer’s instructions (Table 2-21). The molar ratio of 
1:1, insert:vector, has been optimised in the pGEM®-T Easy Vector system. All 
components were mixed and incubated at RT for 1 hour.  
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Table 2-21. Composition of the ligation reaction using the cDNA product and 
pGEM®-T Easy Vector. 
Component Quantity (10 µl reaction) 
2 X Rapid ligation buffer, T4 DNA Ligase 5 µl 
pGEM®-T Easy Vector (50 ng) 1 µl 
cDNA insert 0.8 – 1 ng * 
T4 DNA Ligase (3 Weiss units µl-1) 1 µl 
Nuclease-free water to 10 µl 
*based on a 1:1 molar ratio of insert:vector. 
The ligation reaction was directly transformed into chemically competent E. coli 
DH5α as in section 2.1.1. Transformants were screened for the insert by colony 
PCR as in section 2.1.8.1. Plasmids containing the insert were extracted using the 
Qiagen Miniprep kit as per manufacturer’s instructions and sequenced by the 
Massey Genome Sequencing Service. 
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2.2 Results & Discussion 
2.2.1 Purification of FitB 
To biochemically characterise activity of FitB we needed to stabilise purified 
protein to avoid degradation before or during ribonuclease activity assays. Previous 
attempts in our lab to stabilise FitB by purifying with 10% glycerol resulted in 
relatively stable but inactive FitB (Joanna Hicks, unpublished, 2017). We tested the 
stabilisation effects of 1% Triton X-100 and 5% glycerol by adding these to the 
FitB purification buffers. As the addition of detergents has the potential to interfere 
with activity we also tested the stability of FitB when kept at low temperatures for 
the duration of the purification steps.  
FitB was successfully purified by IMAC with the addition of 1% Triton X-100 and 
5% glycerol in the purification buffers. The chromatogram of the IMAC 
purifications under each condition and the corresponding SDS-PAGE gels (Figure 
2-2) show FitB elutes at approximately 30 - 35% elution buffer, corresponding to 
300 – 350 mM imidazole. Non-specific, unbound proteins elute early in the elution 
gradient (flow through). The 280 nm trace of these proteins (at 0 – 20 ml) was 
cropped out of the chromatogram for scaling purposes to emphasise the peak of 
interest (peak fraction). To assess if FitB was in its native, folded form, the peak 
fraction was run on a Native-PAGE gel which, unlike SDS-PAGE, does not 
denature the proteins. There appeared to be a small amount of FitB in its native 
form from the purification with 1% Triton X-100 as indicated by faint bands on the 
Native-PAGE gel (Figure 2-2d), however, it could not be used in ribonuclease 
activity assays as the protein precipitated out of solution after a very short time. No 
bands corresponding to folded FitB could be seen on the Native-PAGE gel of the 
purification with 5% glycerol (Figure 2-2d) signifying FitB was unfolded and thus 
of no use in ribonuclease activity assays.  
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Figure 2-2. IMAC purification and protein analysis of FitB purified with 1% Triton 
X-100 and 5% glycerol. (a, b) Chromatograms from purification with 1% Triton 
X-100 (a) and 5% glycerol (b) depict the UV absorbance (280 nm) and elution of FitB 
under each condition. The flow through fractions (0 – 20 ml) are cropped out for 
scaling purposes. (c) 15% SDS-PAGE gel shows non-specific proteins (flow through, 
F/T) and protein eluted at 30 – 35% elution buffer (peak fraction). (d) 12% Native-
PAGE gel of proteins in the F/T and peak fraction. (c, d) FitB is indicated by a black 
arrow. Molecular weight of each band is determined from a Precision Plus Protein 
Standard ladder. Molecular weight (kDa) values are labelled. 
The third method trialled to stabilise FitB was keeping the protein at a low 
temperature before and after purification. This was achieved by keeping the cell 
lysate on ice or at 4 °C during sonication and centrifugation prior to purifying (see 
Section 2.1.3 for details). The fraction collection tubes were set up on ice so FitB 
was exposed to low temperatures once eluted from the column. The chromatogram 
of this IMAC purification and the corresponding SDS and Native-PAGE gels 
(Figure 2-3) show under these conditions FitB elutes from the column with 
approximately 20% elution buffer (corresponding to 200 mM imidazole). 
Interestingly, on the SDS-PAGE gel there is a band corresponding to FitB (approx. 
16 kDa), suggesting some FitB expressed in the E. coli expression host is insoluble 
(Figure 2-3b). As the concentration of soluble FitB in the peak fraction was 
sufficient for our requirements we did not investigate the insoluble protein further. 
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Native-PAGE analysis revealed FitB was in its native, folded form (Figure 2-3c). 
When attempting to concentrate FitB using spin concentrators it rapidly precipitated 
out of solution. Unconcentrated FitB stored on ice appeared to precipitate after 
approximately 2 hours. To avoid precipitation of FitB by concentration, the 
maximum possible volume of FitB (6 µl), after buffer and substrate were accounted 
for, was added to the ribonuclease activity assays (see Section 2.1.10.2). 
 
Figure 2-3. IMAC purification of FitB on ice and protein analysis. (a) Chromatogram 
depicts the UV absorbance (280 nm) and elution of FitB. 0 - 35 ml at the beginning of 
the chromatogram has been cropped for scaling purposes. (b) 15% SDS-PAGE gel 
shows insoluble protein (I), soluble protein (S) and protein eluted at approx. 20% 
elution buffer (peak fraction). (c) 12% Native-PAGE gel of protein eluted in the peak 
fraction. (b, c) FitB is indicated by a black arrow. Molecular weight of each band is 
determined from a Precision Plus Protein Standard ladder. Molecular weight (kDa) 
values are labelled. 
Out of the three methods trialled, both the addition of Triton X-100 and maintaining 
the protein at low temperatures resulted in protein in its native, folded form, 
however this folded form was short lived as both methods resulted in precipitated, 
unfolded protein after short time periods. Maintaining FitB at low temperatures kept 
FitB soluble for longer so this method was selected for future purifications. This 
method also had the advantage of not adding components, such as detergents, that 
could interfere with the ribonuclease activity assays. 
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Many VapC proteins are insoluble when expressed in E. coli and purified without 
VapB. Mycobacterial VapC proteins are only soluble when expressed and purified 
as the VapBC complex (McKenzie et al., 2012a; Robson et al., 2009). Robson et 
al. (2009) attempted to express and purify VapB and VapC from M. smegmatis 
individually in an E. coli expression system but found neither were soluble. 
Similarly, VapC from M. tuberculosis could not be purified on its own so was 
obtained by expressing and purifying the VapBC complex followed by a trypsin 
digest to degrade VapB and anion exchange chromatography to isolate VapC 
(McKenzie et al., 2012a). The insolubility of VapC during expression is 
presumably due to its toxicity to the host. VapCPAE0151 protein from P. aerophilum 
is an exception as it can be expressed and purified on its own using an E. coli 
expression and purification system (Bunker et al., 2008). However, VapCPAE0151 is 
only soluble at pH 9.2 which would negate any toxicity issues to E. coli. FitB is 
also an exception as it is soluble when expressed on its own in E. coli, at neutral 
pH, although it is very unstable in solution following purification. We took 
advantage of this by using an E. coli expression system and stabilising FitB during 
purification to prolong protein integrity for the duration of the ribonuclease activity 
assays. 
2.2.2 Producing a negative control for ribonuclease assays  
A negative control was required for the ribonuclease activity assays to ensure any 
cleavage of the RNA substrates was due to ribonuclease activity of FitB and not an 
artefact of the pentaprobe system or a result of contaminating ribonucleases from 
the purification step or in the assay buffers.  
2.2.2.1 FitAB toxin-antitoxin complex 
FitAB was purified by IMAC (see section 2.1.4) and eluted from the column at 20% 
elution buffer, corresponding to approx. 200 mM imidazole (Figure 2-4). Both FitA 
and FitB were present in the peak fraction (Figure 2-4b). On the SDS-PAGE gel, a 
prominent band at approximately 8.4 kDa in the insoluble fraction indicated a large 
portion of FitA was insoluble. Analysis by Native-PAGE indicated there was 
disproportionately more FitB protein in its native, folded form than there was FitA 
(Figure 2-4c). Due to the large presence of FitA in the insoluble fraction and the 
instability of antitoxins in TA systems it is probable FitA unfolded during the 
purification process.  
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Figure 2-4. IMAC purification of FitAB and protein analysis. (a) Chromatogram 
depicts the UV absorbance (280 nm) and elution of FitAB. 0- 35 ml at the beginning 
of the chromatogram has been cropped for scaling purposes. (b) 15% SDS-PAGE gel 
shows insoluble protein (I), soluble protein (S) and protein eluted at approx. 20% 
elution buffer (peak fraction). (c) 12% Native-PAGE gel of protein eluted in the peak 
fraction. (b, c) FitB is indicated by a black arrow, FitA is indicated by a grey arrow. 
Molecular weight of each band is determined from a Precision Plus Protein Standard 
ladder. Molecular weight (kDa) values are labelled. 
Unexpectedly, when FitAB was added to the ribonuclease activity reactions, the 
RNA pentaprobes were cleaved in the same way as the FitB ribonuclease activity 
reactions (Figure 2-5). This would have been a consequence of FitA degradation 
during purification, leaving active FitB. FitAB was therefore not an appropriate 
negative control for the ribonuclease activity assays.  
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Figure 2-5. Ribonuclease activity assays with FitAB control on a 10% urea-
denaturing PAGE gel. The RNA substrate is labelled at the top (Pentaprobe 932). 
Reactions consist of RNA only control (R), FitAB negative control (FitAB), FitB with 
EDTA (E) and FitB (FitB). Size of bands are indicated by a Low range ssRNA ladder 
on right side of gel, bases are labelled. 
2.2.2.2 FitB mutant 
Previously in our lab, ribonuclease activity of VapCPAE0151 from 
Pyrobaculum aerophilum was abrogated by mutating aspartic acid (Asp92) to 
asparagine and glutamic acid (Glu38) to glutamine (Duyvestyn, 2012). These 
residues are highly conserved in the catalytic site of PIN-domains (Arcus et al., 
2011) so mutation to positively charged residues alters the charge of the catalytic 
pocket, preventing cations from binding and subsequently preventing magnesium-
dependent ribonuclease activity. We attempted to inhibit the ribonuclease activity 
of FitB by mutating the homologous PIN-domain residues, Asp104 and Glu42. Using 
inactive FitB as a negative control would ensure the ribonuclease activity is due to 
the PIN-domain active site of FitB and not an artefact of the purification system or 
the buffers. 
The first method used to generate the FitB mutants was the two-halves mutagenesis 
method. For each mutant, the forward and reverse half of the gene is amplified 
individually with primers containing the desired mutation. Each half is annealed in 
a single PCR reaction to generate the complete mutated gene. Agarose gel 
electrophoresis showed the PCR reactions were successful as the PCR products 
seen on the gel were the correct size (Figure 2-6). The fitB D104N mutagenesis 
forward reaction generated a 329 base-pair (bp) product and the reverse reaction 
generated a 133 bp product (Figure 2-6a). FitB E42Q mutagenesis forward reaction 
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generated a 142 bp product and the reverse reaction generated a 310 bp product 
(Figure 2-6c). The subsequent PCR reaction, using each half reaction, resulted in 
complete gene products, 417 bp long, for both fitB D104N and fitB E42Q 
mutagenesis (Figure 2-6).  
 
Figure 2-6. PCR products of the two-halves mutagenesis reactions on 1% TAE 
agarose gels. (a) FitB D104N forward and reverse half sequences. (b) FitB D104N 
complete gene product. (c) FitB E42Q forward and reverse half sequences. (d) FitB 
E42Q complete gene product. Negative controls (Neg.) show no amplification. The size 
of the bands are indicated by a 1 kb+ ladder, number of bases are labelled. 
The PCR products were ligated into the pET28b-pstI plasmid, between PstI and 
XhoI restriction sites, and transformed into chemically competent E. coli DH5α. 
Transformed colonies were screened for the presence of plasmid with the gene 
insert by colony PCR followed by agarose gel electrophoresis of the PCR product 
(Figure 2-7). There were no more than four colonies from each of the 
transformations so they were all taken for screening by colony PCR. Two of the 
colonies from the D104N transformation contained plasmids with the insert, 
represented by a 620 bp band on the agarose gel (Figure 2-7). The third colony 
contained plasmid without the insert, represented by a faint band at 362 bp on the 
agarose gel (Figure 2-7). All four colonies from the E42Q transformation contained 
plasmid with no insert (Figure 2-7) suggesting the fitB E42Q gene was not ligated 
into the plasmid.  
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Figure 2-7. Colony PCR reactions on a 1% TAE agarose gel screening for plasmids 
containing mutated fitB genes following transformation into E. coli DH5α. Each lane 
contains PCR amplified plasmid from a single colony transformed with fitB D104N 
plasmid (D104N) or fitB E42Q plasmid (E42Q). Each lane is labelled + (plasmid with 
gene insert) or – (no or empty plasmid). Plasmid containing the gene insert is indicated 
by a white arrow and labelled. Empty plasmid is indicated by a white circle. The PCR 
negative control (Neg.) has no plasmid DNA. The size of the bands are indicated by a 
1 kb+ ladder, number of bases are labelled. 
Sequencing of the plasmids with the fitB D104N gene mutation from the two 
positive transformants revealed the aspartic acid codon was successfully mutated to 
the arginine codon (Figure 2-8). However, two adenine bases in the gene sequence 
had been deleted (Figure 2-8), causing a frame shift in the codon sequence so the 
protein would be incorrectly translated.  
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Figure 2-8. Pairwise alignment of fitB pET28b-pstI with fitB D104N plasmid 
synthesised by two-halves mutagenesis. Only the alignment from nucleotides 925 - 
1122 is shown. The sequencing chromatogram shows the signal intensities of each 
nucleotide (A, red; T, green; C, blue; G, yellow). The nucleotide sequence is given for 
each sequence with the translated amino acid sequence immediately underneath. The 
deletion in fitB D104N sequence is indicated by a black box. The mutation from 
aspartic acid (D) to asparagine (N) is indicated by a red circle. 
We were unable to generate the E42Q mutant by this protocol so we tried a site-
directed mutagenesis method using Platinum SuperfiTM DNA polymerase. In 
contrast to mutagenesis by the two-halves method, where two halves of the 
sequence were mutated then joined together, the site-directed mutagenesis method 
introduces a point mutation directly into circular plasmid DNA. Template DNA is 
removed by DpnI digestion, as this targets methylated DNA, leaving plasmid 
containing the desired mutation.  
To confirm the presence of mutated plasmid following PCR and DpnI digestion, 
the PCR reaction for E42Q mutagenesis was run on an agarose gel (Figure 2-9). 
The high-molecular weight band seen on the gel corresponds to full-length plasmid, 
fitB pET28b-pstI (Figure 2-9). The negative control did not contain plasmid 
template so the low-molecular weight band on the gel is most likely primer-dimers 
(Figure 2-9). After transforming the PCR product into E. coli DH5α and extracting 
the plasmid, the plasmid DNA was sequenced. The glutamic acid residue had been 
correctly mutated to glutamine, however, the primer sequence was duplicated in the 
plasmid sequence (Figure 2-10) so the protein could not be expressed. 
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Figure 2-9. PCR product from the fitB E42Q site-directed mutagenesis reaction on a 
1% TAE agarose gel. The PCR reaction (E42Q) contains a band at approx. 5600 bp 
corresponding to the plasmid DNA. The negative control (Neg.) contains a small band 
corresponding to primer-dimers. The size of the bands are indicated by a 1 kb+ ladder 
with bp values labelled. 
 
Figure 2-10. Pairwise alignment of fitB pET28b-pstI with fitB E42Q plasmid 
synthesised by site-directed mutagenesis. The alignment from nucleotides 175 -261 is 
shown. The sequencing chromatogram shows the signal intensities of each nucleotide 
(A, red; T, green; C, blue; G, yellow). The nucleotide sequence is given for each 
sequence with the translated amino acid sequence immediately underneath. The 
duplicated sequence in fitB E42Q and misalignment with fitB is denoted by a black 
box. The mutation from glutamic acid (E) to glutamine (Q) is indicated by a red circle. 
Neither of the mutagenesis protocols used resulted in viable mutants to express and 
use in the ribonuclease activity assays as a negative control. Due to time constraints, 
we were unable to trouble-shoot and optimise the mutagenesis reactions so 
alternative avenues were investigated for a negative control. 
2.2.2.3 Cysteine biosynthesis protein, CysE 
Concurrently to this project, a protein involved in cysteine biosynthesis in 
N. gonorrhoeae was being expressed and purified in our lab using the same 
protocols as for FitB. This protein, CysE, is a serine acetyltransferase which 
catalyses the acetylation of L-serine to O-acetylserine, the first step in the synthesis 
of L-cysteine (Hicks & Mullholland, 2018; Kredich & Tomkins, 1966). The 
structure of CysE does not resemble that of ribonuclease proteins (Olsen et al., 2004) 
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and functional studies have not shown any ribonuclease activity (Kredich & 
Tomkins, 1966; Pye et al., 2004). Therefore, as CysE was cloned, expressed and 
purified the same as FitB it was chosen as a negative control for the ribonuclease 
activity assays. This ensures cleavage of pentaprobe RNAs by FitB is not an artefact 
of the pentaprobe system or due to contaminating ribonucleases from the 
purification step. 
2.2.3 Ribonuclease activity of FitB 
Pentaprobe RNAs differ in sequence and, over the suite of RNAs, cover every 
combination of five bases. FitB was screened for ribonuclease activity against 
pentaprobe RNA substrates 922, 923, 924, 925, 926, 927 and 932. Pentaprobe 932 
is the complementary sequence of pentaprobe 926 so, presumably, if FitB is a 
sequence-specific ribonuclease, both pentaprobes would be cleaved in the same 
way. Nonetheless, Pentaprobe 932 was included in ribonuclease activity testing as, 
if it was cleaved well by FitB, we had the suite of RNA oligos already in the lab 
from M. smegmatis activity screens (McKenzie et al., 2012a).  
Preliminary assays were stopped by the addition of formamide loading dye after 
five, 15 and 30 minutes incubation to determine the length of time for optimal 
activity of FitB. FitB exhibited ribonuclease activity after a minimum of five 
minutes (Figure 2-11) but 30 minutes incubation allowed for more efficient 
fragmentation of all the pentaprobes.   
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Figure 2-11. Ribonuclease activity time-course assay on a 10% urea-denaturing 
PAGE gel. Each set of reactions are labelled with the name of the RNA pentaprobe 
substrate (Pentaprobe 922 and Pentaprobe 923) accordingly. All reactions with FitB 
are labelled with the time at which they were stopped (five min, 5, 15 min, 15, 30 min, 
30). Negative controls consisted of RNA only, R, and FitB with EDTA, E. Each band 
corresponds to an RNA fragment in the reaction, with lower molecular weight bands 
appearing lower on the gel.  
Based on these ribonuclease activity assays all subsequent activity screens were 
carried out for 30 minutes. FitB displayed ribonuclease activity against all the 
pentaprobes tested (Figure 2-12). Each pentaprobe was cleaved at different 
positions yielding different sized RNA fragments (Figure 2-12). The differing 
banding patterns across different pentaprobe RNA transcripts suggests FitB targets 
a specific sequence and/or secondary structure. The number of bands on the urea-
PAGE gel is indicative of the amount of times FitB cuts the RNA substrates. Some 
pentaprobes have a few prominent bands while others have multiple small bands 
(Figure 2-12). It is likely that FitB has an optimal cut site and other suboptimal cut 
sites that are present in these pentaprobe sequences, consistent with the 
ribonuclease activity seen for other VapC proteins (McKenzie et al., 2012a; 
McKenzie et al., 2012b). The banding patterns for all the pentaprobes tested are 
different from that seen by VapC proteins from M. smegmatis (McKenzie et al., 
2012b), P. aerophilum (McKenzie et al., 2012a) and M. tuberculosis (Sharrock et 
al., 2018) indicating the sequence-specific activity of FitB is unique to this protein 
and is not an artefact of the pentaprobe assay. 
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The EDTA reaction is used as a negative control as it chelates Mg2+ ions to inhibit 
the Mg2+-dependent ribonuclease activity of FitB. Ribonuclease activity of FitB 
was greatly reduced with the addition of EDTA but not inhibited completely (Figure 
2-12). This could be due to carryover of Mg2+ or other divalent cations when 
purifying FitB. As FitB was expressed on its own (without FitA) it is possible that 
FitB coordinated a metal-cation present in E. coli and maintained the ion in its 
catalytic centre during purification. Consequently, when FitB was added to the 
ribonuclease reactions, some of the protein would be in its active state without 
needing Mg2+ from the assay buffer. If the interaction between Mg2+ and the 
catalytic residues of FitB is stronger than the attraction of Mg2+ to EDTA then this 
would explain why there is some residual activity in the EDTA control reactions. 
In this scenario, free cations in the buffer would be chelated but the active FitB 
proteins from the purification would be able to act on the substrate. When the same 
reactions were tested with other VapC proteins (McKenzie et al., 2012a; McKenzie 
et al., 2012b; Sharrock et al., 2018) the EDTA control inhibited total activity of 
VapC. In these assays, VapC was expressed and purified with its cognate VapB 
antitoxin followed by a trypsin digest to degrade VapB (McKenzie et al., 2012a; 
McKenzie et al., 2012b; Sharrock et al., 2018). By purifying VapC in this way, the 
catalytic centre where Mg2+ is coordinated would have been blocked by an arginine 
residue of VapB, preventing VapC from coordinating Mg2+ when expressed in 
E. coli. Therefore, when VapC was added to the pentaprobe reactions it only 
became active once coordinating Mg2+ from the assay buffer, or in the case of the 
EDTA control, remained inactive as all the Mg2+ would have been chelated by 
EDTA. 
The cysteine biosynthesis protein, CysE, was used as a control to ensure cleavage 
was a result of FitB activity and not ribonuclease contamination from the expression 
or purification steps. The pentaprobe RNA transcripts showed no fragmentation 
upon incubation with CysE in place of FitB (Figure 2-12), confirming ribonuclease 
activity is specific to FitB. 
Of all the RNA pentaprobes screened, Pentaprobe 923 showed the simplest banding 
pattern when cleaved by FitB, with three prominent RNA fragments on a urea-
PAGE gel, approximately 100-nt, 75-nt and 50-nt long (Figure 2-12). There are also 
some fainter bands present on the gel, less than 50-nt long, suggesting the 
Chapter Two: Ribonuclease Activity of FitB 
54 
pentaprobe is further fragmented into smaller stands which could be due to multiple 
cut sites on the pentaprobe.  
To further investigate the cut site(s) targeted by FitB on pentaprobe 923 we 
designed shorter oligos, approximately 30-nt long, based on the pentaprobe 
sequence. Five oligos were designed with ten bases overlapping at each end to 
ensure all possible nucleotide combinations within the sequence were covered. 
Based on the results from the pentaprobe assay, we hypothesised at least one of the 
shorter oligos would contain a cut site so would be cleaved by FitB, provided the 
ribonuclease activity was sequence-specific. The results of the oligonucleotide 
assays were assessed on a urea-denaturing PAGE gel (Figure 2-13).  
 
Figure 2-13. Oligonucleotide ribonuclease activity assay on a 15% urea-denaturing 
PAGE gel. There are three reactions per oligo: RNA only (R), FitB with EDTA (E) 
and FitB (FitB). Each set of reactions are labelled with the name of the RNA 
oligonucleotide substrate accordingly. The set of oligonucleotides is based on the RNA 
Pentaprobe 923 sequence. The size of bands is indicated by a low range ssRNA ladder 
on the left of the gel, bases are labelled.  
Contrary to our hypothesis, none of the oligos were cleaved by FitB. Intriguingly, 
there appears to be a band in the wells and more ‘smearing’ of higher molecular 
weight products higher on the urea gel for the assays that contained FitB (FitB and 
the FitB with EDTA control) but not in the RNA only controls (Figure 2-13). The 
same feature is seen in the pentaprobe assays (Figure 2-12). This is likely FitB 
bound to RNA, which would be too large to migrate through the gel so remains in 
the wells or runs higher on the gel due to its increased molecular weight.  
RNA binding has been seen for M. smegmatis VapC (McKenzie et al., 2012b) and 
M. tuberculosis VapC4 (Sharp et al., 2012) but not for other M. tuberculosis VapCs, 
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Rv0065 and Rv0617 (Ahidjo et al., 2011) suggesting this characteristic is unique 
to certain VapC proteins. It is evident, FitB can bind RNA without cleaving it. This 
is also seen for VapC4 which binds short RNA oligos, 30-nt long, at specific 
sequences (ACGC or AC(A/U)GC) without cleaving them (only 2% of the bound 
RNA was cleaved) (Sharp et al., 2012). RNA binding by VapC4 was proposed to 
be a mechanism of translation inhibition in vivo, more-so than the actual cleavage 
of RNA (Sharp et al., 2012). Due to structural homology, it is possible FitB also 
binds mRNA transcripts at a specific sequence to inhibit translation in 
N. gonorrhoeae.  
The lack of ribonuclease activity against RNA oligos by FitB differs from the 
activity seen by VapC proteins from M. smegmatis (McKenzie et al., 2012b), 
P. aerophilum (McKenzie et al., 2012a) and M. tuberculosis (Sharrock et al., 2018). 
Each of these VapC proteins cleaved shorter oligos that corresponded to a cut 
pentaprobe. Interestingly, the ribonuclease activity displayed by M. smegmatis 
VapC against the oligos was much less efficient than the cleavage of the full length 
pentaprobe (McKenzie et al., 2012b). Further investigation into this revealed the 
importance of secondary structure in conjunction with the target sequence for 
optimal RNA cleavage by M. smegmatis VapC (McKenzie et al., 2012b). 
McKenzie et al. (2012b) found M. smegmatis VapC cleaves the RNA sequence 
AUA(U/A) where there is a hairpin structure immediately downstream (Figure 
2-14). Secondary structures associated with three experimentally cut sequences 
were predicted using RNAfold as part of the Vienna RNA secondary structure 
server (Hofacker, 2003) and aligned with 39 genes to build a consensus model of 
the most probably sequence and structure motif targeted by VapC (Figure 2-14). 
Based on comparison between RNA substrates with variations of the predicted 
target motif it was concluded that VapC cuts RNA most efficiently at the predicted 
cut site, and will cut substrates without the complete motif but to a lesser extent 
(Figure 2-14).  
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Figure 2-14. Models of RNA secondary structure targeted by M. smegmatis VapC. (a) 
Secondary structure consensus model. (b) Schematic diagrams of RNA substrates 
showing the presence or absence of the consensus model motif. MSMEG_2124 and 
MSMEG_2121 are genes downregulated by VapC. The extent of ribonuclease (RNase) 
activity is scored from +, weak activity, to ++++, strong activity, and X, no activity. 
Figures retrieved from (McKenzie et al., 2012b). 
Secondary structure is also important for RNA cleavage by other M. tuberculosis 
VapC proteins (Winther et al., 2016; Winther et al., 2013). The secondary structure 
of the Sarcin-Ricin loop of 23S rRNA is important for VapC20 cleavage as activity 
is abolished when the stem is modified or removed (Winther et al., 2013). Given 
structural homology, it is likely that FitB recognises specific secondary structures 
as do the VapC proteins described above. Based on the results from our 
ribonuclease activity assays, we compared the secondary structures of the 
pentaprobes and the oligos to assess whether this could have affected activity of 
FitB. The secondary structures were predicted using RNAfold (Figure 2-15 & 
Appendix B.2.) (Hofacker, 2003). 
The secondary structures of the oligos are distinct from that in the parent 923 
pentaprobe (Figure 2-15). Pentaprobe 923 forms several hairpin structures with an 
open strand of nucleotides on the 5’ end (Figure 2-15), much like the secondary 
structure motif targeted by M. smegmatis VapC (McKenzie et al., 2012b). The 
oligos, however, do not possess a similar structure. Despite having a secondary 
structure preference, other VapC proteins still cleaved the shorter oligos. As FitB 
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did not cleave the oligos at all, secondary structure targets might be strictly limited 
suggesting FitB is highly specific toward certain cellular targets. 
 
Figure 2-15. Secondary structures of Pentaprobe 923 and oligos predicted using 
RNAfold. Grey lines around the pentaprobe represent the portion of the pentaprobe 
that the labelled oligo matches. Nucleotide colours indicate the probability of base-
pair folding as shown on the colour scale (purple, zero, red, one).  
To characterise the sequence-specificity of VapC proteins from M. smegmatis 
(McKenzie et al., 2012b), P. aerophilum (McKenzie et al., 2012a) and 
M. tuberculosis (Sharrock et al., 2018) the sequence of the cut oligonucleotides was 
determined using MALDI-TOF MS. By this method, the masses of each cut 
fragment from the oligonucleotide activity assays (like above) were determined and 
the VapC cut site(s) was deduced (McKenzie et al., 2012a; Sharrock et al., 2018). 
We were unable to use this method to determine the cut site of FitB as the short 
oligonucleotides were not cut by FitB and the longer pentaprobes are too long for 
MALDI-TOF MS analysis. MALDI-TOF MS is a highly sensitive method when 
using small RNA, however, the mass resolution decreases with an increase in RNA 
length (Kirpekar et al., 1994). 
We aimed to develop a similar MS approach to analyse the larger pentaprobe 
sequences. We worked in consultation with Grant Smolenski at MS3 Solutions and 
began developing a method using HPLC followed by MS. HPLC is important for 
separating the cut fragments before measuring their mass by electrospray ionisation 
mass spectrometry (ESI-MS). 
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To prepare the RNA for HPLC and MS analysis, the buffers for purification and for 
the activity assays needed to be altered to contain no sodium ions. Sodium ions tend 
to form adducts with RNA which interferes with the masses measured by MS 
(Thomas & Akoulitchev, 2006). The purification buffer was changed to a Tris 
buffer and the assay buffer was changed to ammonium phosphate. This did not 
affect the purification of FitB nor did it affect the activity of FitB in pentaprobe 
assays. We have taken 2 µg purified pentaprobe 923 RNA and pentaprobe 923 RNA 
fragments after cleavage by FitB to MS3 solutions and are currently waiting for 
analysis to see if this method is feasible. 
An alternative approach to determining putative target cut sites of FitB is 
sequencing cDNA synthesised from the cut RNA fragments. The protocol for 
obtaining cDNA was designed using a combination of different protocols and 
enzymes (Farrell Jr, 2009; Gubler & Hoffman, 1983). It is not a straight forward 
reverse-transcription reaction because we do not know where the pentaprobes are 
cut which means we cannot design sequence-specific primers.  
The first cDNA strand is synthesised by circular reverse-transcription PCR (RT-
PCR) with random-hexamer primers. Each RNA fragment is circularised to ensure 
the full length sequence is reverse-transcribed, regardless of where the random-
hexamer primers bind. If the primers were to bind randomly along the linear 
fragments we would not be able to identify if the cDNA was synthesised from the 
full length RNA fragment or partially synthesised due to misplacement of the 
primers. Circular RT-PCR produces an RNA:cDNA hybrid with the first cDNA 
strand bound to the RNA template.  
The second cDNA strand is synthesised from the RNA:cDNA hybrid by nick 
translation. This involves a cocktail of enzymes each with a different role in the 
reaction. RNase H nicks the RNA strand in the RNA:cDNA hybrid in several places 
to form short segments that act as primers (Farrell Jr, 2009). DNA Pol I adds 
nucleotides to the end of the ‘primers’ using cDNA as a template for transcription. 
RNA fragments downstream of active DNA Pol I are digested by the enzyme as it 
transcribes the DNA. T4 DNA ligase repairs breaks in the second cDNA strand 
following DNA Pol I transcription to produce a complete double-stranded DNA 
product.  
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For sequencing, blunt ends are generated on each end of the DNA product and the 
product is inserted into an annotated plasmid vector, pGEM®-T Easy. The plasmid 
can be sequenced using primers flanking the insertion region so the sequence of 
DNA can be determined. 
To date, we have tested this method twice, however, have not been successful in 
obtaining DNA sequences. The reaction to synthesise the second cDNA strand 
requires optimisation as the RNA:cDNA hybrid is degraded during this step. Due 
to the complex nature of this reaction it is unsurprising that the conditions need 
optimising to ensure all enzymes are working efficiently. This protocol is currently 
being optimised.  
2.3 Conclusions 
FitB can be expressed and purified on its own without its cognate antitoxin, FitA. 
This is unlike many other VapC proteins which must be purified as the VapBC 
complex, followed by a trypsin digest to remove VapB (McKenzie et al., 2012a; 
Robson et al., 2009). Despite being soluble, purified FitB is unstable in solution 
making it difficult to characterise its activity. We have developed a method to 
stabilise FitB during purification to ensure the protein remains in its native, folded 
form for the duration of ribonuclease activity assays.  
FitB is a ribonuclease with sequence and structural specificity. FitB cuts RNA 
pentaprobes, approx. 160-nt long, but does not cleave short, 30-nt RNA oligos of 
the same sequence. We, therefore, predict secondary structure is important for RNA 
cleavage by FitB. The secondary structures of the RNA oligos is significantly 
different to that of the pentaprobes which would explain why activity is seen with 
one substrate but not the other. Intriguingly, FitB displays RNA binding properties 
by binding both the RNA pentaprobes and oligos. RNA binding by FitB occurs 
regardless of RNA cleavage suggesting both are important functions of FitB.  
Methods to determine the target cut site sequence(s) of FitB have been established 
and are currently under development.  
2.4 Future Research 
The HPLC-MS approach described in this chapter will continue to be developed to 
determine the cut site sequence(s) of FitB. If it is too difficult to analyse the 
pentaprobe ribonuclease activity assays using this approach, cDNA from the cut 
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RNA fragments will be synthesised and sequenced, as discussed, and the cut sites 
will be deduced by comparing sequences of the cut RNA fragments with the 
original pentaprobe sequence. The secondary structure targeted by FitB will also be 
characterised by further ribonuclease activity assays using RNA substrates with 
known secondary structures. RNA binding by FitB will be investigated by gel 
electrophoretic mobility shift assays, as reported by Sharp et al. (2012), to assess 




3 Chapter Three 
The Role of FitAB in Intracellular Replication  
3.1 Introduction 
During infection of the human urogenital tract, N. gonorrhoeae invades human 
epithelial cells and traffics through to the other side, exiting into the subepithelial 
layer (Billker et al., 2002; Evans, 1977; Wang et al., 1998). Although the 
mechanism of adherence and invasion is well understood, little is known about the 
intracellular lifecycle of N. gonorrhoeae or the molecular mechanisms driving 
intracellular trafficking.  
A study by Hopper et al. (2000) investigated molecular mechanisms of intracellular 
trafficking using a transposon mutagenesis screen. Hopper et al. (2000) identified 
fast intracellular traffickers with mutations in a single locus containing two open 
reading frames, fitA and fitB. One transposon was inserted upstream of both genes, 
the other inserted within the fitB gene (Figure 1-4). Further investigation into the 
effects of these mutations revealed an increase in intracellular growth rate 
associated with the faster trafficking phenotype (Figure 3-1) (Hopper et al., 2000).  
 
Figure 3-1. Graphs showing transepithelial trafficking and intracellular replication 
by N. gonorrhoeae WT and N. gonorrhoeae fitAB gene deletion strains. (a) Rate of 
epithelial trafficking depicted by percent of T84 monolayers transcytosed at various 
time-points (hours, hrs) and (b) intracellular growth rate in A431 human epithelial 
cells represented by percent of CFU present at zero hour (hr) for N. gonorrhoeae 
MS11 wild-type (white bars/boxes) and N. gonorrhoeae MS11 fitAB gene deletion 
strain (black bars/boxes). Retrieved from (Hopper et al., 2000). 
(a) (b)
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Although fitA and fitB were identified as being translationally coupled (Hopper et 
al., 2000), it was not known at the time that they constituted the FitAB toxin-
antitoxin (TA) system, belonging to the VapBC superfamily (Arcus et al., 2011; 
Mattison et al., 2006). In other bacteria, VapBC TA systems have been implicated 
in the regulation of intracellular growth to generate bacteriostatic/persistent cell 
populations (McKenzie et al., 2012b; Sharrock et al., 2018; Winther & Gerdes, 
2011). N. gonorrhoeae has the ability to enter a state of persistence, causing 
asymptomatic infection (Workowski & Berman, 2007). We hypothesise that the 
VapBC TA system, FitAB, is important for generation of this persistent state. 
In M. smegmatis, VapC regulates cell growth by cleaving mRNA transcripts 
involved in carbon transport and glycerol metabolism (McKenzie et al., 2012b). To 
understand how FitAB regulates growth of N. gonorrhoeae we must determine its 
biological targets, which can be elucidated by comparing intracellular replication 
of N. gonorrhoeae wild-type (WT) and N. gonorrhoeae fitAB gene deletion strains 
(ΔfitAB) and analysing gene expression during infection.  
In this chapter, we characterise the role of FitAB in N. gonorrhoeae by extending 
the intracellular growth experiment conducted by Hopper et al. (2000) and extract 
RNA from N. gonorrhoeae at different time-points throughout the experiment in 
preparation for transcriptome analysis.  
3.2 Materials & Methods 
3.2.1 Human epithelial cell culture 
3.2.1.1 Culturing A549 human lung epithelial cells 
Stocks of A549 human lung epithelial cells were stored in Freezing Media (80% 
1 X DMEM/F12 (Gibco), 10% fetal calf serum (FCS, Gibco) and 10% dimethyl 
sulfoxide (DMSO)) at -80 °C. To establish a cell culture, a stock of cells was thawed 
at 37 °C with 5% CO2 for 10 min and centrifuged at 3000 g for 5 min. All DMSO 
was removed, with caution not to disrupt the cell pellet, and the cell pellet was 
resuspended in 1 ml 10% Cell Culture Media (1 X DMEM/F12, 10% FCS, 
2.5 µg ml-1 vancomycin, 1 µg ml-1 amphotericin B) by gentle pipetting and 
transferred to a vented cell culture flask containing 4 ml of pre-warmed 10% Cell 
Culture Media. The flask was then incubated at 37 °C with 5% CO2 for 
approximately 15 hours. Following incubation, the Cell Culture Media was 
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replaced with fresh, pre-warmed 10% Cell Culture Media. Once the cells had grown 
to approximately 80% confluency, media was replaced with pre-warmed 1% Cell 
Culture Media (1 X DMEM/F12, 1% FCS, 2.5 µg ml-1 vancomycin, 1 µg ml-1 
amphotericin B) to maintain cell cultures. Media was then refreshed every three 
days. 
3.2.1.2 Detaching A549 cells from culture flasks  
To detach epithelial cells from cell culture flasks, all media was removed and cells 
were washed with 2 ml Washing Media (1 X DMEM/F12, 2.5 µg ml-1 vancomycin, 
1 µg ml-1 amphotericin B). Washing Media was removed before addition of 1 ml 
0.25% Trypsin-EDTA (TE) including Phenol Red (Gibco) to cover the base of the 
flask. Cell cultures were then incubated at 37 °C for 3 min to detach cells.  
3.2.1.3 Splitting A549 cell cultures 
A549 cells were detached from the flasks as above (section 3.2.1.2). Suspended 
cells (in TE) were transferred to pre-warmed 10% Cell Culture Media. The volume 
of cell culture media depended on how many new cell cultures were required. Cells 
were dispersed through the cell culture media by gently inverting before 
transferring into new cell culture flasks in 5 ml aliquots. Cultures were incubated at 
37 °C with 5% CO2 for 15 hours. The media was replaced with fresh pre-warmed 
10% Cell Culture Media and returned to incubate at 37 °C with 5% CO2 until cells 
became confluent.  
3.2.1.4 Freezing A549 cell cultures 
Cells were detached (section 3.2.1.2) and transferred into 9 ml 10% Cell Culture 
Media. Cells were pelleted by centrifugation at 2000 g for 30 min. All supernatant 
was removed and cells were resuspended in 4 ml Freezing Media. Cells were 
transferred into cryovials in 1 ml aliquots and placed in a controlled rate freezing 
apparatus for cell culture. This was placed in a -80 °C freezer overnight. The 
following day, cells were transferred to a freezer box for long-term storage at -80 °C. 
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3.2.2 Bacteria cell culture 
Glycerol stocks of N. gonorrhoeae FA1090 WT and N. gonorrhoeae FA1090 
ΔfitAB were stored at -80 °C. 
3.2.2.1 Growth on solid media  
N. gonorrhoeae was cultured on either supplemented chocolate agar plates (Fort 
Richard Laboratories) or GCB agar plates. 
GCB-agar plates were poured fresh according to the method in (Dillard, 2011). In 
brief, 36.25 g GC Medium Base (Difco) and 1.25 g agar was added to 1 L water. 
The solution was autoclaved and cooled to 50 - 60 °C. Immediately before pouring 
into plates, 10 ml (per 1 L) Iso Vitalex supplement (BD Biosciences) was added to 
the agar. Plates were poured with approximately 20 ml agar per plate and set at 
room temperature (RT). GCB-agar plates were stored at 4 °C for up to a week.  
N gonorrhoeae glycerol stocks were streaked onto agar plates and incubated 
upside-down at 37 °C with 5% CO2. 
3.2.2.2 Growth in liquid media 
A sterile loop was used to transfer colonies from agar plates (section 3.2.2.1) to 
5 ml pre-warmed 10% Cell Culture Media in a vented cell culture flask. Flasks were 
incubated overnight at 37 °C with 5% CO2.  
3.2.3 Intracellular replication experiment 
Two A549 cell cultures were grown from cell culture stocks as described in section 
3.2.1.1. Once confluent, each culture was split into ten new cultures using the 
method described in section 3.2.1.2. For each culture, 1 ml of cells in TE buffer was 
added to 49 ml 10% Cell Culture Media and aliquoted into ten flasks in 5 ml 
aliquots, giving a total of 20 new cell cultures. These cultures were incubated for 
36 hours at 37 °C with 5% CO2 until cells were 80% confluent. Each cell culture 
was split again into two new cultures to yield 40 A549 cell cultures which were 
returned to 37 °C with 5% CO2 until confluent.  
Prior to infection with N. gonorrhoeae, A549 cell cultures were counted using a 
BioRad Cell Counter. Cells were detached from the flasks as in section 3.2.1.2 and 
transferred into 1.5 ml tubes. BioRad cell counter slides for each culture were 
loaded with 10 µl of cells and placed in the BioRad cell counter for automatic 
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counting. The remaining cells were centrifuged at 13,000 g for 1 min. The 
supernatant was removed from each tube and the cell pellets were resuspended in 
1 ml pre-warmed 10% Cell Culture Media. This was transferred to individual cell 
culture flasks containing 4 ml 10% Cell Culture Media. Cells were incubated for 
1 hour at 37 °C with 5% CO2 to allow cells to adhere to the flasks. 
Three N. gonorrhoeae FA1090 WT and three N. gonorrhoeae FA1090 ΔfitAB 
cultures were set up as in Section 3.2.2.2. After incubation for 15 hours at 37 °C 
with 5% CO2 the optical density (OD) at 600 nm was measured using a 
spectrophotometer blanked with 10% Cell Culture Media. The cultures were 
considered ready for infection when cell growth was high (OD600 > 1.0). Each A549 
culture was infected with 100 - 150 µl bacterial cells (the inoculation volume was 
adjusted to account for variations in OD of each culture). Each culture of 
N. gonorrhoeae was used to infect six A549 cell cultures. After inoculation, flasks 
were returned to 37 °C with 5% CO2 for 14 hours to allow bacteria to invade the 
cells. After 14 hours, 10 µl of 20 mg ml-1 gentamicin was added to each flask 
containing A549 cells and N. gonorrhoeae, and mixed by swirling. Flasks were 
returned to 37 °C with 5% CO2 for 1 hour. Following incubation, media was 
removed and cells washed with pre-warmed Washing Media twice to remove any 
extracellular bacteria and gentamicin. Fresh 10% Cell Culture Media was added to 
each flask and all were returned to 37 °C with 5% CO2, except for six flasks (one 
of each inoculum) which were processed as the zero hour time-point.  
At zero, six, eight, ten, 14 and 24 hours post-gentamicin treatment six cell cultures 
(one of each N. gonorrhoeae inoculum) were removed from incubation to harvest 
the intracellular bacteria. To harvest the bacteria, all media was removed and each 
culture was washed twice with 3 ml Washing Media. Cells were detached from 
flasks (section 3.2.1.2) and transferred to a 1.5 ml tube. Cells were pelleted by 
centrifugation at 5000 g for 2 min. All supernatant was removed and the cells 
washed with Washing Media before further centrifugation. The supernatant was 
removed and cell pellets were resuspended in 500 µl of 0.5% Saponin, made up 
fresh in 1 X phosphate-buffered saline (PBS), vortexed briefly and gently mixed 
for 7 to 8 min by inversion until the solution was less opaque (indicating epithelial 
cells lysis). Lysed epithelial cells were centrifuged as above and the supernatant 
was removed. Cell pellets were resuspended in Washing Media and centrifuged to 
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pellet as above. All Washing Media was removed and the cell pellet resuspended 
in 200 µl Washing Media.  
Intracellular replication of N. gonorrhoeae was calculated by measuring colony 
forming units (CFUs) grown on agar plates. The bacteria harvested from A549 cells 
were resuspended in 200 µl Washing Media (undiluted), and a dilution series 
prepared including a 10-2 dilution, and 10-4 dilution with Washing Media. The 
dilution series was prepared by transferring 2 µl undiluted bacteria to 198 µl 
Washing Media and vortexing to mix. This was repeated again, transferring 2 µl of 
the diluted sample to another tube of 198 µl Washing Media and vortexing to mix. 
Five microliters of each dilution was pipetted three times (technical replicate) onto 
pre-warmed chocolate agar or GCB-agar plates. Plates were incubated upside-down 
at 37 °C with 5% CO2 overnight and colonies counted the following morning (see 
section 3.2.3.1). 
The undiluted bacteria from above were centrifuged at 13,000 g for 2.5 min. Cell 
pellets were resuspended in 500 µl 5 M guanidinium thiocyanate (GITC), made up 
fresh in DEPC-treated water, and transferred to 1.5 ml screw cap tubes containing 
0.3 g of 0.1 mm and 4 x 2.5 mm zirconia beads, prebaked at 120 °C overnight 
(bead-beating tubes). These were immediately transferred to -80 °C freezer for 
storage.  
3.2.3.1 Data analysis of CFU measurements 
The colony forming units (CFUs) counted from the agar plates were analysed in 
Excel. CFUs were converted to cells ml-1 using Equation 1.  
Equation 1. Conversion from CFU to cells ml-1 
𝐶𝐹𝑈 × 𝑑𝑖𝑙𝑢𝑡𝑖𝑜𝑛 𝑓𝑎𝑐𝑡𝑜𝑟 × 0.005 𝑚𝑙 = 𝑐𝑒𝑙𝑙𝑠 𝑚𝑙−1 
These values were normalised by converting to a percentage of the amount of cells 
present at zero hour using Equation 2 for each mutant.  
Equation 2. Normalisation of cell counts at each time-point in relation to cells present 
at zero hour. 
(
𝑐𝑒𝑙𝑙𝑠 𝑚𝑙−1
0 ℎ𝑟 𝑐𝑒𝑙𝑙𝑠 𝑚𝑙−1
) × 100% = % 𝑜𝑓 0 ℎ𝑟 
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The average of each technical replicate was plotted as a scatter plot (time vs percent 
of intracellular CFU) using GraphPad Prism 7.04. A trendline based on the mean 
values was fit for each mutant. A multiple t-test was performed using the Holm-
Sidak method (alpha = 0.05) in GraphPad Prism 7.04 to determine statistical 
significance. The P value for each time-point was marked statistically significance 
if p < 0.05.  
3.2.4 General methods used for RNA extraction 
3.2.4.1 Sodium acetate and ethanol precipitation 
To purify RNA from other contaminating phenols or salts, 1/10th of the volume of 
3 M sodium acetate, pH 5.2, was added to RNA suspended in water, followed by 
2.5 volumes of ice-cold 200 proof ethanol. Samples were mixed gently by inverting 
several times then incubated at -20 °C overnight. Following incubation, samples 
were centrifuged at 13,000 g for 15 min at 4 °C to pellet the RNA. All the 
supernatant was removed and the pellet was washed with 1 ml of 70% ethanol. 
Samples were centrifuged at 13,000 g for 5 min at 4 °C. All traces of ethanol were 
removed and the RNA pellet air dried for 5 min before resuspension in 10 - 20 µl 
nuclease-free water.  
3.2.4.2 DNase treatment 
Contaminating DNA was removed using PerfeCTa DNase I (QuantaBio) as per 
manufacturer’s instructions. A 30 µl reaction was set up (Table 3-1). All reagents 
were added to the 1.5 ml tube of RNA while on ice. The reaction was vortexed 
gently to mix and centrifuged briefly to collect components at the bottom of the 
tube. The reaction was incubated at 37 °C, shaking at 300 rpm for 30 min. 
Following incubation, the reaction was stopped by addition of 3 µl 10 X Stop 
Buffer. The reaction was vortexed again and centrifuged briefly before incubation 
at 65 °C for 10 min. The reaction was returned to ice and RNA purified by sodium 
acetate and ethanol precipitation (section 2.1.10.1) and resuspended in 20 µl water. 
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Table 3-1. Composition of the PerfeCta DNase I (QuantaBio) reaction. 
Composition Quantity (30 µl reaction) Concentration 
RNA Template 10 µl  
10X reaction buffer 3 µl 1 X 
PerfeCta DNase I (2 U µl-1) 3 µl 0.2 U µl-1 
RNase/DNase free water to 30 µl  
 
3.2.4.3 Agarose gel electrophoresis  
Agarose gels were made up to 1% agarose with TAE buffer and 1 X SYBR safe 
DNA gel stain (Invitrogen). RNA samples were mixed 1:1 with 2 X formamide 
loading dye and heated to 75 °C for 5 min before loading onto the gels. Gels were 
run at 100 V for 40 min and visualised using an iBright imager (Invitrogen). Band 
sizes were determined based on comparison with a 1 Kb plus DNA ladder 
(Invitrogen). 
3.2.4.4 Qubit® RNA Broad-Range (BR) assay 
RNA concentration was measured using a Qubit® RNA BR assay kit (Invitrogen) 
and a Qubit® Fluorometer (Invitrogen). The Qubit® RNA BR assay kit measures 
RNA concentrations between 0.05 ng µl-1 and 6 ng µl-1 after dilution. All samples 
were prepared and measured in thin-wall, clear 0.5 ml PCR tubes (Axygen® PCR-
05-C tubes). Qubit® working solutions were set up by diluting the Qubit® RNA BR 
Reagent 1:200 in Qubit® RNA BR Buffer as per manufacturer’s instructions. Two 
standards and RNA samples were prepared as in Table 3-2, vortexed briefly and 
incubated at RT for 2 min. The Qubit® Fluorometer was calibrated with the 
standards, and samples were read. All measurements were corrected for the 200 
fold dilution. Where the RNA concentration was outside the measurement range for 
this kit, a result of > 6 ng µl-1 (after dilution) was given. 
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Table 3-2. Composition of Qubit® RNA standard and sample assays. 
Composition Standards  
(200 µl reaction) 
Samples 
(200 µl reaction) 
Qubit® working solution 190 µl 199 µl 
Standard (from kit) 10 µl - 
RNA sample - 1 µl 
 
3.2.5 Methods used to optimise RNA extraction 
RNA extraction methods were tested and optimised using 5 ml of N. gonorrhoeae 
culture grown in 10% Cell Culture Media (section 3.2.2.2). The yield and quality 
of the RNA extracted by each method was assessed by NanoDropTM, agarose gel 
electrophoresis (refer to section 3.2.4.3) and Qubit® RNA analysis (refer to section 
3.2.4.4). 
3.2.5.1 TRIzol® Reagent with bead-beating 
N. gonorrhoeae FA1090 WT was cultured as in section 3.2.2.2. Cultures were 
transferred to 1.5 ml tubes and centrifuged at 13,000 g for 2 min to pellet cells. The 
supernatant was removed and the pellet was resuspended in 1 ml TRIzol® Reagent 
(Invitrogen) and transferred to bead-beating tubes as in section 3.2.3. Samples were 
frozen at -80 °C.  
Samples were removed from the -80 °C freezer and thawed at RT. Cells were lysed 
by bead beating using a FastPrep cell disrupter (FP120 Thermo Savant) for 30 sec 
at setting 6.5, left to cool for 30 sec, and repeated three more times at setting 6.0, 
5.5 and 5.0 respectively. Two hundred microlitres of chloroform was added and 
samples were mixed on a rotating wheel for 3 min at RT. Samples were then 
centrifuged at 13,000 g for 15 min at 4 °C to separate the aqueous and organic 
phases. The upper aqueous phase containing RNA was transferred to a new tube 
and 500 µl isopropanol was added before incubating at -20 °C overnight to 
precipitate the RNA.  
Samples were then spun at 13,000 g for 20 min at 4 °C to pellet the RNA. All 
isopropanol was removed and the RNA pellet washed with 1 ml 70% ethanol. 
Samples were vortexed briefly before spinning at 7500 g for 10 min at 4 °C. All 
traces of ethanol were removed. RNA was air dried briefly and resuspended in 20 µl 
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of nuclease free water. RNA was purified by sodium acetate and ethanol 
precipitation (section 2.1.10.1). Contaminating DNA was removed by DNase 
treatment (section 3.2.4.2) followed by an additional sodium acetate and ethanol 
precipitation (section 2.1.10.1) and resuspended in 20 µl nuclease-free water. 
3.2.5.2 TRIzol® Reagent with lysozyme 
N. gonorrhoeae FA1090 WT was cultured as in section 3.2.2.2. Cultures were 
transferred to 1.5 ml tubes and centrifuged at 13,000 g for 2 min to pellet cells and 
all supernatant removed. Cell pellets were resuspended in 500 µl lysozyme buffer 
(30 mM Tris, 10 mM EDTA, 10 mg ml-1 lysozyme, pH 6.2) and incubated at 37 °C 
for 30 min. One millilitre of TRIzol® Reagent and 300 µl chloroform was added to 
samples and mixed well by pipetting before centrifugation at 13,000 g for 20 min 
at 4 °C. The upper aqueous phase was transferred to a new tube followed by 
addition of 300 µl saline solution (0.6 M NaCl, 0.4 M sodium citrate) and 300 µl 
isopropyl ethanol. Samples were then mixed by inverting and stored at -20 °C 
overnight to precipitate RNA. Samples were centrifuged at 13,000 g for 20 min at 
4 °C and all supernatant removed. The RNA pellet was washed with 1 ml 70% 
ethanol and centrifuged for a further 10 min at 7500 g. All traces of ethanol were 
removed and the RNA pellet air dried. The RNA was dissolved in 50 µl nuclease-
free water and contaminating DNA was removed by DNase treatment (section 
3.2.4.2), followed by purification by sodium acetate and ethanol precipitation 
(section 2.1.10.1). 
3.2.5.3 Lysis method 
N. gonorrhoeae FA1090 WT was cultured as in section 3.2.2.2. Cultures were 
transferred to 1.5 ml tubes and centrifuged at 13,000 g for 2 min to pellet cells and 
all supernatant removed. The pellet was resuspended in 600 µl lysis buffer (TE 
buffer, 0.006% SDS, 0.12 mg ml-1 Proteinase K) and vortexed. The reaction was 
incubated for 1 hour at 37 °C, shaking at 300 rpm. Cells were lysed when the 
solution turned clearer. An equal volume of acid-phenol/chloroform (1:1, v/v) was 
added and mixed well by inverting until it appeared monophasic. Samples were 
centrifuged at 13,000 g for 5 min at RT to separate the phases. A distinct white layer 
containing protein was formed at the interface. The upper aqueous phase was 
transferred to a new tube and the phenol/chloroform phase separation steps repeated 
until no white interface was observed. To remove the phenol from the aqueous 
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phase an equal volume of chloroform was added and mixed by inverting. The 
solution was centrifuged at 13,000 g for 5 min and the upper aqueous phase 
transferred to a new tube. RNA was precipitated by adding 2.5 volumes of ice-cold 
200 proof ethanol, mixed gently and incubated at -20 °C for a minimum of 30 min. 
RNA was centrifuged at 13,000 g for 15 min at 4 °C and all ethanol removed. The 
RNA pellet was washed with 1 ml 70% ethanol and centrifuged at 13,000 g for 
2 min. All ethanol was removed and the pellet briefly air dried. The RNA was 
resuspended in 15 µl RNase free water and heated at 55 °C for 10 min to solubilise 
the RNA. Contaminating DNA was removed by DNase treatment (section 3.2.4.2), 
followed by purification by sodium acetate and ethanol precipitation (section 
2.1.10.1). 
3.2.5.4 GITC/phenol/bromo chloropropane isolation 
N. gonorrhoeae FA1090 WT was cultured as in section 3.2.2.2. Cultures were 
transferred to 1.5 ml tubes and centrifuged at 13,000 g for 2 min to pellet cells and 
all supernatant removed. The pellets were resuspended in 500 µl 5 M GITC and 
transferred to bead-beating tubes (refer to section 3.2.3) and frozen at -80 °C.  
Samples frozen in 5 M GITC were thawed at RT and lysed using a Precellys 24 
New Generation tissue homogenizer. Cells were lysed by two rounds of bead 
beating for 20 sec at 4000 rpm, with a 1 min rest in between to allow the samples 
to cool. The homogenized samples were centrifuged at 13,000 g for 5 min at 4 °C 
to remove any foam. A phenol and bromo-chloropropane (BCP) phase separation 
was performed by addition of 1/10th of the volume of 2 M sodium acetate, pH 4, 
and an equal volume of acid-phenol, pH 4, with a brief vortex to mix. The samples 
were placed on a rotating wheel for 10 min at RT followed by addition of 100 µl 
BCP. Samples were shaken for 1 min then incubated on ice for 5 min. Samples were 
centrifuged at 13,000 g for 1 min at 4 °C to separate the aqueous phase, interphase 
and organic phase. The upper aqueous phase containing the RNA was transferred 
into a new tube and the phenol and BCP phase separation was repeated until no 
white interface was present. An equal volume of isopropanol was added to the 
aqueous layer and incubated overnight at -20 °C to precipitate RNA. 
Samples were then centrifuged at 13,000 g for 15 min at 4 °C to pellet the RNA. 
All traces of isopropanol were removed and the RNA pellet dissolved in 100 µl of 
10 mM Tris-HCl, pH 7.0 and 0.5 mM MnCl2. Samples were DNase treated by the 
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addition of 2.5 µl Promega RQ1 DNase. Reactions were incubated at 37 °C at 
350 rpm for 30 min followed by the addition of 300 µl viral extraction solution 
(5.2 M guanidium thiocyantate, 2 M guanidine HCl, 2 M urea). Samples were 
incubated at RT for 5 min on a rotating wheel. Four hundred microliters of 
isopropanol was added, and samples were incubated for 10 min at RT and 
centrifuged at 13,000 g for 15 min at RT. All supernatant was removed and RNA 
pellets washed with 1 ml 70% ethanol and centrifuged at 13000 g for 5 min at RT. 
All traces of ethanol were removed and RNA pellets dissolved in 200 µl nuclease-
free water and 200 µl of 5 M lithium chloride. Samples were incubated at -20 °C 
for 1 hour then centrifuged at 13,000 g for 15 min at 4 °C. RNA pellets were 
resuspended in 100 µl nuclease-free water, purified by sodium acetate and ethanol 
precipitation (section 2.1.10.1) and resuspended in 30 µl nuclease-free water.  
3.2.5.5 Modified GITC/phenol/bromo chloropropane isolation 
The GITC/phenol/BCP isolation method (section 3.2.5.4) was modified to optimise 
for extraction of RNA from N. gonorrhoeae. N. gonorrhoeae FA1090 WT cell 
cultures were grown and frozen in 5 M GITC as in section 3.2.5.4. Samples were 
thawed at RT and lysed using a Precellys 24 New Generation tissue homogenizer 
(two rounds of bead beating for 20 seconds at 4000 rpm with a 1 min rest). 
Homogenised samples were centrifuged at 13,000 g for 5 min at 4 °C followed by 
phenol and BCP phase separation and isopropanol precipitation (refer to section 
3.2.5.4). 
Samples were centrifuged at 13,000 g for 15 min at 4 °C to pellet RNA. All traces 
of isopropanol were remove, RNA was dissolved in 100 µl nuclease-free water, and 
300 µl viral extraction solution was added. Samples were incubated at RT for 5 min 
on a rotating wheel. Four hundred microliters of isopropanol was added and 
samples were incubated for a further 10 min at RT before centrifugation at 13,000 g 
for 15 min at RT. All supernatant was removed and the RNA pellet washed with 
1 ml 70% ethanol, followed by centrifugation at 13,000 g for 5 min at RT. All traces 
of ethanol were removed and the RNA pellet air dried for 5 min before dissolving 
in 10 µl nuclease free water. Contaminating DNA was removed by DNase 
treatment (section 3.2.4.2) followed by purification by sodium acetate and ethanol 
precipitation (section 2.1.10.1). 
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3.2.6 Preparation of RNA for sequencing 
Total RNA to be sequenced was extracted from N. gonorrhoeae grown within 
epithelial cells during the intracellular replication experiment (refer to section 3.2.3) 
using the modified GITC/phenol/BCP method (refer to section 3.2.5.5). The RNA 
was stored in 75% ethanol at -80 °C. Samples were shipped frozen, on ice, to BGI 
Tech Solutions, Hongkong, for transcriptome analysis (RNA-Seq).  
3.3 Results & Discussion 
To assess the role of FitAB in persistence, we performed intracellular replication 
experiments. These involved infecting A549 human lung epithelial cells with 
N. gonorrhoeae WT and N. gonorrhoeae ΔfitAB strains and measuring intracellular 
bacterial growth over time. This experiment was originally carried out by Hopper 
et al. (2000) but only over a 10 hour time-course. Our aim was to repeat the 
experiment as in Hopper et al (2000) but extend the time course and extract RNA 
from various time-points for transcriptome analysis. 
3.3.1 Intracellular replication experiment 
Intracellular replication experiments using N. gonorrhoeae typically involve 
infection of human epithelial cells then, 14 hours post initial infection, treatment 
with gentamicin to remove extracellular bacteria. At specific time-points post 
gentamicin treatment (including a zero hour time-point immediately after treatment) 
epithelial cells are lysed to release intracellular bacteria. Bacteria are then plated 
onto agar plates and bacterial growth determined.  
The intracellular replication experiment described in this chapter was first carried 
out in our lab by Dr. Joanna Hicks prior to the start of this MSc research. She 
optimised the lysis protocol using saponin for the extraction of bacteria from within 
epithelial cells and also checked for extracellular growth of bacteria post gentamicin 
treatment to ensure colonies counted were a true indicator of intracellular 
replication. 
Upon beginning this MSc project the first aim was to optimise the intracellular 
replication experiment. We first conducted this experiment using some materials 
that differ from what is described in section 3.2.3; rather than GCB-agar, the 
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bacteria were cultured using supplemented chocolate agar plates, and 1 X PBS was 
used for the wash steps.  
Each A549 epithelial cell culture contained on average 2.14 x 106 cells. The average 
OD600 of the inoculation cultures of N. gonorrhoeae was 1.46. Bacteria were 
harvested from the epithelial cells at six different time-points, zero, six, eight, ten, 
14 and 24 hours following gentamicin treatment and CFUs were counted. Growth 
curves were generated from the CFU counts for N. gonorrhoeae FA1090 WT and 
N. gonorrhoeae FA1090 ΔfitAB (Figure 3-2). P-values were determined for each 
time-point (Table C-2). 
 
Figure 3-2. Comparison of intracellular growth of N. gonorrhoeae FA1090 WT strain 
(circles) and N. gonorrhoeae FA1090 ΔfitAB deletion strain (squares) from the first 
intracellular growth experiment. Growth is shown as percentage of CFU at zero hour 
verse time (hours). Each point represents a biological replicate. Trendlines were fit 
based on the means of each strain at each time-point. No time-points were determined 
as statistically significant (p > 0.05 for all time-points).  
Following gentamicin treatment, to remove extracellular bacteria, the population of 
intracellular WT and ΔfitAB bacteria declines, until approximately six hours when 
the ΔfitAB population begins to replicate again (Figure 3-2). The WT bacteria are 
delayed at resuming replication as this population of bacteria does not increase until 
ten hours post-gentamicin treatment. This trend aligns with findings by Hopper et 
al. (2000), although in their experiment ΔfitAB bacteria began to replicate after just 
four hours following gentamicin treatment. The intracellular population of ΔfitAB 
bacteria more than doubles in size between six to ten hours then declines 
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dramatically at 14 hours while WT bacteria double in population between ten and 
14 hours (Figure 3-2). Growth steadily declines for both ΔfitAB and WT between 
14 and 24 hours. The rapid decline in population of ΔfitAB bacteria is suggestive of 
a sudden cell death event. This is intriguing because WT bacteria do not undergo 
the same rapid decline in population and there is only one reported event of another 
TA deletion system presenting the same phenotype (Frampton et al., 2012). An 
M. smegmatis triple TA deletion mutant, in which three different TA loci, mazEF, 
vapBC and phd/doc, were deleted, displayed rapid cell death after a period of 
normal growth, while growth of single and double deletion mutants remained 
unchanged (Frampton et al., 2012). It is interesting that M. smegmatis only displays 
this phenotype when three different TA systems are deleted whereas 
N. gonorrhoeae was affected by a single TA deletion. This suggests FitAB may be 
more important for intracellular survival of N. gonorrhoeae than the other TA 
systems.  
As the dispersal of data at each time-point was broad, and none of the comparisons 
were statistically significant, we collated data from the first intracellular replication 
experiment with an independent experiment performed by Dr. Joanna Hicks 
(unpublished, 2017) (Figure 3-3). The experiment performed by Dr. Joanna Hicks 
did not contain CFU counts at 14 hours post-gentamicin treatment so, consequently, 
there are less data points on the graph at the 14 hour time-point. The trendlines show 
the average CFU at each time-point. The change in intracellular growth over the 
time course is consistent with the trend seen in the initial experiment (Figure 3-2). 
Statistical analysis resulted in p-values (Table C-3) greater than 0.05 for zero, six, 
eight and 14 hour time-points, suggesting the error in CFU counts at these time-
points was too great to determine statistical significance. 
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Figure 3-3. Comparison of intracellular growth of N. gonorrhoeae FA1090 WT strain 
(circles) and N. gonorrhoeae FA1090 ΔfitAB deletion strain (squares) grown in human 
A549 epithelial cells. Growth is shown as percentage of CFU at zero hour verse time 
(hours). Data is collated from two individual experiments and each point represents 
a biological replicate. Trendlines were fit based on the means of each strain at each 
time-point. Asterisks signify statistical significance at the corresponding time-point (p 
< 0.05). 
In an attempt to reduce error in the CFU counts we consulted Prof. So whom we 
originally obtained the strains from and is an expert in Neisseria research. Based on 
her recommendations we made some modifications. In initial experiments, cell 
suspensions were washed with 1 X PBS, however, after consultation with Prof. So 
it was thought this may have been reducing N. gonorrhoeae cell viability as PBS is 
known to increase lysis of N. gonorrhoeae. Therefore, 1 X PBS was replaced with 
cell culture media without FCS (Washing Media) for all wash steps. This would 
reduce bacterial cell lysis and improve cell viability as bacteria would already be 
acclimatised to this media. The solid media on which N. gonorrhoeae was cultured 
was changed from supplemented chocolate agar plates to GCB-agar containing 
nutritional supplements. Unlike chocolate agar, GCB-agar is transparent so light 
microscopy can be used to evaluate the morphology and the presence of Type IV 
pili on bacterial colonies.  
N. gonorrhoeae use Type IV pili to attach to and invade epithelial cells (Swanson 
et al., 1987). Expression of pilus proteins is phase variable meaning expression can 
be switched on and off. Upon exposure to epithelial cells, the pilus proteins are 
switched on, however, by inoculating epithelial cell cultures with N. gonorrhoeae 
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already expressing pili, invasion would be more efficient. It was therefore important 
to identify colonies expressing pilus proteins versus colonies not expressing pili. 
Piliated colonies can be identified by a dark ring around the edge of the colony. 
We identified colonies with dark rings and cultured these in liquid media. These 
cultures did not grow the same as in previous experiments. Previously, cultures of 
N. gonorrhoeae appeared yellow (due to a change in pH of the culture media) and 
opaque after overnight incubation (at 37 °C with 5% CO2). Cultures grown from 
piliated colonies, however, formed numerous clumps without clouding the media. 
The clumping is due to the pili on the cells causing the bacteria to attach to each 
other and form microcolonies. To assess the difference this would make to invasion 
of epithelial cells, we repeated the intracellular replication experiment using these 
cultures as an inoculum. Due to clumping of the bacteria, measuring the OD was 
difficult but care was taken to ensure each epithelial cell culture was inoculated 
with the same amount of bacteria. As data are processed as a percent of the zero 
hour time-point, slight differences in the amount of bacteria used for inoculation 
would be accounted for.  
This experiment resulted in the same trend of intracellular growth between zero and 
14 hours as seen previously in that intracellular replication of the ΔfitAB deletion 
strain was faster compared to the WT strain (Figure 3-4). However, the overall 
change in growth over the course of the experiment was less than observed in 
previous experiments. This was surprising as we predicted the infection rate, and 
therefore intracellular CFU count, would be greater by inoculating the epithelial 
cells with piliated bacteria. This may have been due to the epithelial cells being 
inoculated with less bacteria compared to previous experiments. The OD600 values 
of N. gonorrhoeae cultures used in this experiment were approximately 0.5 ± 0.2 
whereas in previous experiments cultures had an OD600 of approximately 1.2 ± 0.1. 
It is also possible that due to the bacteria clumping, the dispersal of bacteria was 
not even throughout the epithelial cell culture causing some cells to be more heavily 
invaded than others. Bacteria in heavily invaded epithelial cells would have a limit 
to their intracellular replication while epithelial cells not infected by bacteria would 
not have any intracellular growth. Therefore, the total CFU counts of intracellular 
growth would not be representative of the whole epithelial cell culture.  
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Interestingly, intracellular replication increased after 14 hours for both WT and 
ΔfitAB bacteria. Despite being a plausible growth curve for WT bacteria, this was 
unexpected for ΔfitAB bacteria as the population had already declined between ten 
and 14 hours and the opposite trend was seen in the previous experiments (Figure 
3-3). It also goes against our understanding of intracellular growth when TA 
systems are deleted from other bacteria as replication tends to decrease and does 
not increase again (Frampton et al., 2012). It is possible that this trend is a result of 
a low inoculum and not a true representation of intracellular growth, however 
further investigation is needed.  
 
Figure 3-4. Comparison of intracellular growth of N. gonorrhoeae FA1090 WT strain 
(circles) and N. gonorrhoeae FA1090 ΔfitAB deletion strain (squares) grown from a 
low inoculum in human A549 epithelial cells. Growth is shown as percentage of CFU 
at zero hour verse time (hours). Each point represents a biological replicate. 
Trendlines were fit based on the means of each strain at each time-point. Asterisks 
signify statistical significance at the corresponding time-point (p < 0.05). 
When cultured in media only, there is no difference in growth rate between 
N. gonorrhoeae WT and N. gonorrhoeae ΔfitAB strains over 24 hours (Figure 3-5) 
(Hopper et al., 2000)(Joanna Hicks, unpublished, 2017). This indicates FitAB only 
regulates growth of N. gonorrhoeae within human epithelial cells. It is hypothesised 
that when growing extracellularly, the FitAB complex is in its stable, inert form 
bound to the fitAB operon (Mattison et al., 2006; Wilbur et al., 2005). Upon 
invasion of human epithelial cells, an as yet un-identified stimuli, such as cellular 
proteases, pH or nutritional deprivation, triggers the degradation of FitA causing 
dissociation of the complex, dysregulated transcription of the operon, and release 







N o rm a lis e d  %  3 1 1 0 1 8  3
T im e  p o s t  g e n ta m ic in
tr e a tm e n t  (h o u r s )
W T























Chapter Three: The Role of FitAB in Intracellular Replication 
79 
of active FitB (Mattison et al., 2006). As with other VapC proteins (Sharrock et al., 
2018; Winther & Gerdes, 2011) FitB is toxic to the cell, thus active FitB causes cell 
growth to slow or cease altogether, resulting in slower intracellular replication. 
 
Figure 3-5. Comparison of growth in culture media of N. gonorrhoeae FA1090 WT 
strain (circles) and N. gonorrhoeae FA1090 ΔfitAB deletion strain (squares). Growth 
is shown as optical density at 600 nm verse time (hours). (Joanna Hicks, Unpublished, 
2017). 
3.3.2 Optimising RNA extraction  
Extraction of RNA from N. gonorrhoeae was optimised for bacteria grown in 
culture prior to extraction of RNA from bacteria grown intracellularly. Several 
RNA extraction methods were trialled: TRIzol® Reagent with bead beating, 
TRIzol® Reagent with lysozyme, a Lysis method, GITC/phenol/BCP isolation, and 
a modified method of the GITC/phenol/BCP isolation. RNA extracted by each 
method underwent quantitative and qualitative analysis to determine which 
achieved RNA of a high enough quality and quantity for RNA sequencing.  
The first RNA extraction method we trialled used TRIzol® Reagent with physical 
cell lysis by bead beating. TRIzol® is a pre-mixed reagent containing phenol and 
GITC (Farrell Jr, 2009) designed to isolate RNA, DNA and protein from cell or 
tissue samples (Simms et al., 1993). Addition of chloroform aids phase separation, 
isolating RNA in the aqueous phase and DNA and proteins in the organic phase 
(Farrell Jr, 2009). We trialled RNA extraction using the TRIzol® method as it has 
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been successfully used in previous work to extract RNA from N. gonorrhoeae 
(Nudel et al., 2018; Remmele et al., 2014; Yu et al., 2016).  
This method yielded reasonable concentrations of RNA (Table 3-3) however the 
absorbance ratios at OD260/280 and OD260/230 were lower than 2.0 (Table 3-3), 
which is desired for pure RNA. The OD260/280 ratios of 1.7 - 1.9 suggested the 
presence of DNA, however these ratios did not improve after the DNase treatment. 
Prior to purification of the RNA by sodium acetate and ethanol precipitation (see 
section 2.1.10.1) the OD260/230 ratios were below 2.0 (Table 3-3) indicating 
potential contamination by phenols, peptides, or carbohydrates. This contamination 
was likely due to the high concentration of GITC in the TRIzol® Reagent (Cicinnati 
et al., 2008; Luebbehusen) which increases the absorbance at 230 nm, lowering the 
OD260/230 ratio. Purification of RNA by sodium acetate and ethanol precipitation 
proved important for removing the GITC carry-over, indicated by an improvement 
in OD260/230 ratios to over 2.0 following this step (Table 3-3).  
To assess the integrity of total RNA on an agarose gel, bands of 23S rRNA and 16S 
rRNA should be present in approximately a 2:1 ratio, respectively. In the RNA 
samples extracted using Trizol® and bead-beating, a high molecular weight band 
(23S rRNA) appeared to be present but fainter than the 16S rRNA band suggesting 
large RNA was degraded (Figure 3-6). Following DNase treatment, no bands of 
23S or 16S rRNA were visible on the agarose gel (Figure 3-6) indicating complete 
degradation of the RNA. 
  
Chapter Three: The Role of FitAB in Intracellular Replication 
81 
Table 3-3. Comparison of total RNA extracted using each RNA extraction method. 
The success of each method was quantified based on RNA concentration and 
OD260/280 and OD260/230 ratios as determined by NanoDropTM. The extraction 
method used is labelled on the far left with sample numbers given for each replicate 
that correspond to sample numbers on agarose gel figures. The concentration of RNA 







TRIzol® with bead 
beating  
(before DNase and 
purification) 
1 144.6 1.90 0.98 
 2 67.6 1.74 0.66 
TRIzol® with bead 
beating  
(after DNase and 
purification) 
1 108.5 1.91 2.49 
 2 41.3 1.85 2.38 
TRIzol® with lysozyme 1 22.9 1.53 1.04 
Lysis 1 82 1.8 2.12 
GITC/phenol/BCP 
isolation 
1 2.3 3.19 0.43 
 2 11.6 1.72 1.17 
Modified 
GITC/phenol/BCP 
isolation before DNase 
optimisation 
1 55.9 1.87 0.53 
 2 35.1 1.82 1.05 
Modified 
GITC/phenol/BCP 
isolation with optimised 
DNase step  
1 219 1.99 2.31 
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Figure 3-6. Total RNA extracted from N. gonorrhoeae using TRIzol® with bead 
beating, on 1% TAE agarose gels. (a) Two samples of RNA before DNase treatment 
and purification, sample numbers are labelled, 1 and 2. (b) The same two samples of 
RNA after DNase treatment and purification. The size of the bands are indicated by 
a 1 kb+ ladder on the left of each gel, number of bp are labelled.  
To determine if physically lysing the cells via bead beating was contributing to 
RNA degradation we tested a second method using TRIzol® Reagent with chemical 
lysis. In this method, cells were lysed with lysozyme. This method yielded less 
RNA compared to the physical cell lysis method (Table 3-3) indicating lysozyme 
was not as efficient as bead beating for lysing bacterial cells. Agarose gel 
electrophoresis revealed no RNA bands for the lysozyme sample (Figure 3-7) 
suggesting the concentration of RNA detected by NanoDropTM was in fact 
contamination and any extracted RNA was lost using this method.  
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Figure 3-7. Total RNA extracted from N. gonorrhoeae using TRIzol® with lysozyme 
(L) or TRIzol® with bead beating (B), on a 1% TAE agarose gel. The size of rRNA 
bands are labelled on the right. The size of the bands are indicated by a 1 kb+ ladder 
on the left of each gel, number of bp are labelled. 
The third method tested was a phenol-chloroform RNA extraction with chemical 
cell lysis using SDS and Proteinase K. This method yielded RNA with little phenol 
or salt contamination as indicated by the high OD260/230 ratio (Table 3-3), 
although the OD260/280 ratio suggested contaminating DNA was present, despite 
treating with DNase. The RNA concentration (Table 3-3) was comparable to the 
other methods tested. When visualised on an agarose gel the RNA was degraded 
and nucleotide smearing from a high molecular weight band confirmed the presence 
of contaminating DNA (Figure 3-8). Due to the absence of rRNA bands on the 
agarose gel, DNase treatment was not optimised for this method.  
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Figure 3-8. Total RNA extracted from N. gonorrhoeae by lysis RNA extraction, on a 
1% TAE agarose gel. The size of the bands are indicated by a 1 kb+ ladder on the left 
of each gel, number of bp are labelled. 
The fourth RNA extraction method tested was GITC/phenol/BCP isolation. This 
method has been successful in our laboratory for the extraction of RNA from 
Mycobacteria. This method uses the same principles as TRIzol® isolation except 
the extraction buffers are prepared in the laboratory. GITC and acidic phenol extract 
RNA from the bacteria cells into solution and BCP facilitates the phase separation, 
isolating RNA in the aqueous phase (Chomczynski & Mackey, 1995; Chomczynski 
& Sacchi, 1987). BCP is used in place of chloroform because it is less volatile and 
equally as efficient as chloroform for phase separation (Chomczynski & Mackey, 
1995).  
Initial attempts to extract RNA using this method resulted in very low 
concentrations of RNA (Table 3-3) which was heavily degraded (Figure 3-9a). The 
method was modified by removing the steps involving lithium-chloride. This was 
in part to remove lithium-chloride from the extraction procedure as this degrades 
small RNAs which may be important in the transcriptome analysis. The other 
reason for removing these steps was to reduce the amount of RNA precipitation and 
resuspension steps to minimise the amount of lost RNA. Removal of these steps 
improved the RNA yield (Table 3-3) and integrity (Figure 3-9b). The removal of 
contaminating DNA was optimised by moving the DNase treatment step from 
immediately after isopropanol precipitation to the end of the RNA extraction. This 
was a lot more efficient at removing contaminating DNA as evidenced by an 
OD260/280 ratio of 1.99 (Table 3-3) and the absence of smearing at high molecular 
weights on agarose gels (Figure 3-9c).  
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Figure 3-9. Total RNA extracted from N. gonorrhoeae using (a) the original 
GITC/phenol/BCP isolation method, (b) the modified GITC/phenol/BCP isolation 
method, and (c) the modified GITC/phenol/BCP isolation method with optimisation 
of the DNase step, visualised on a 1% TAE agarose gel. (a, b) Samples are numbered 
1 and 2. (c) Sample a is RNA extracted before the addition of DNase, sample b is after. 
The size of the bands are indicated by a 1 kb+ ladder on the left of each gel, number 
of bp are labelled on the far left. 
After comparing all RNA extraction methods the best quality RNA was obtained 
using the modified GITC/phenol/BCP isolation method with the optimised DNase 
treatment step. This method was used to extract RNA from N. gonorrhoeae 
harvested from the intracellular replication experiments (discussed in section 3.3.3). 
3.3.3 Bacterial RNA extraction from the intracellular replication 
experiments 
Samples of N. gonorrhoeae that had been harvested from the six, eight, ten and 24 
hour time points during an intracellular replication experiment (method in section 
3.3.1) performed by Dr Joanna Hicks, were frozen in 5 M GITC and stored at -
80 °C. RNA was extracted from these samples using the modified 
GITC/Phenol/BCP isolation method (see section 3.2.5.5). The quality of the RNA 
was assessed by NanoDropTM (results from four samples are given in Table 3-4) 
and agarose gel electrophoresis (Figure 3-10), before and after the DNase treatment 
and purification by sodium acetate and ethanol precipitation. 
Evaluation of the RNA prior to the DNase or purification reactions revealed the 
method yielded RNA of high concentration, at least 60 ng µl-1 per sample (Table 
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3-4), and reasonably good integrity based on the presence of 23S and 16S rRNA 
bands on the agarose gel (Figure 3-10a). High molecular weight nucleotide 
smearing on the agarose gel (Figure 3-10a), in conjunction with OD260/280 ratios 
of approximately 1.8 (Table 3-4), indicated contaminating DNA was present. 
OD260/230 ratios were lower than 1.8 (Table 3-4) indicating the presence of other 
contaminants such as phenol or salts. 
To prevent loss of RNA, biological replicates for each time-point were pooled 
before the DNase was added. Analysis by agarose gel electrophoresis (Figure 3-10b) 
revealed large smearing patterns and bands of 23S or 16S rRNA were no longer 
visible suggesting the RNA had degraded during the clean-up process. The 
OD260/280 ratios remained predominantly unchanged suggesting the protocol for 
DNase treatment was not efficient at removing the DNA, despite the initial 
optimisation of the method (discussed in section 3.3.2). The OD260/230 ratio 
(Table 3-4) improved but remained less than 1.8 indicating phenol or salt 
contaminants were still present.  
Table 3-4. NanoDropTM values for four samples of RNA extracted from the 
intracellular replication experiment, before and after DNase treatment. (Note: the 
concentration is higher following DNase treatment because the RNA samples of 
biological replicates were pooled just prior to this step.) 











63.9 1.81 1.09 282.1 1.87 1.68 
ΔfitAB 
6 hr 
61.1 1.84 0.62 173 1.79 1.56 
WT 
24 hr 
65.9 1.77 0.43 99.4 1.84 1.37 
ΔfitAB 
24 hr 
133.0 1.89 0.73 192.7 1.81 1.45 
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Figure 3-10. RNA extracted from N. gonorrhoeae from the intracellular replication 
experiment, visualised on 1% TAE agarose gels. Lanes are labelled with sample ID 
corresponding to those in Table 3-4. (a) Four RNA samples before DNase treatment. 
(b) Seven RNA samples after DNase treatment. The size of the bands are indicated by 
a 1 kb+ ladder on the left (a) and the right (b), number of bp are labelled. 
In order for the extracted RNA to be sequenced by BGI Tech Solutions (BGI), the 
RNA must meet certain requirements of concentration and quality: concentration 
must be greater or equal to 40 ng µl-1, there must be more than 1 µg, the RNA 
integrity number (RIN) value must be greater than 7.0, the ratio of 23S rRNA to 
16S rRNA must be greater or equal to 1.0 and the absorbance ratios of OD260/280 
and OD260/230 must be greater than 1.8. Due to the poor ratio values below 1.8 in 
the above RNA extraction, RNA was not sent to BGI for sequencing. 
To improve the removal of contaminating DNA, the final concentration of DNase 
in the DNase reaction was increased from 0.1 U µl-1 to 0.2 U µl-1. The intracellular 
replication experiment was repeated and RNA was extracted from these samples 
using the modified GITC/Phenol/BCP method and 0.2 U µl-1 DNase.  
The concentration of RNA extracted from these samples was greater than that 
obtained in the previous extraction, with a minimum of 550 ng µl-1 RNA per sample 
of pooled biological replicates (results from four samples are given in Table 3-5). 
Absorbance ratios at OD260/280 were approximately 1.8 - 2.0 (Table 3-5) which is 
indicative of RNA and not DNA. This demonstrated the modified DNase reaction 
was efficient at removing contaminating DNA, more so than the method used 
previously. The OD260/230 ratios were greater than 2.0 indicating little to no 
contamination.  
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Table 3-5. RNA concentrations, OD260/280 and OD260/230 ratios, as measured by 
NanoDropTM and Agilent 2100, of the first batch of samples sent to BGI.  











WT 10hr 590.3 1.82 2.20 4.697 3.1 
ΔfitAB 
10hr 
548.5 1.96 2.25 24 7.1 
WT 14hr 1107.0 2.03 2.16 32 7.6 
ΔfitAB 
14hr 
1415.6 2.05 2.18 210 8.4 
 
Based on the NanoDropTM results, the RNA samples met the requirements for RNA 
sequencing by BGI so four samples (listed in Table 3-5) were sent to BGI for 
sequencing. These samples were selected for RNA sequencing because the 
difference in intracellular growth between the WT and ΔfitAB strains was the 
greatest over the 24 hour time course (Figure 3-3) so would be the most informative 
samples when it came to comparing transcriptomes. 
Prior to library prep, independent tests of the RNA samples were performed by BGI 
using an Agilent 2100 Bioanalyser (Table 3-5). The concentration of RNA for each 
sample was significantly lower than that measured by NanoDropTM (Table 3-5). 
This could have been due to the NanoDropTM measuring free ribonucleotides from 
degraded RNA whereas the Agilent 2100 Bioanalyser measures intact RNA. The 
RIN values were also determined, of which only three of the four samples (Table 
3-5) met the RIN requirement (> 7.0) for sequencing. Sample ΔfitAB 14hr was the 
only sample to pass the BGI sequencing requirements with a concentration greater 
than 40.0 ng µl-1 and a RIN value greater than 7.0 (Table 3-5). For all other samples 
the concentration was too low and for WT 10hr the RIN value was also too low 
(Table 3-5). Consequently, none of the samples were sequenced.  
To achieve a higher concentration of RNA for sequencing, the amount of bacteria 
from which the RNA was extracted from was increased. As this meant handling 
more cell culture flasks during the intracellular replication assay, this optimisation 
step was only carried out for ten and 14 hour time-points, and RNA was only 
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extracted from bacteria harvested at these time-points. The number of culture 
replicates at these time-points was increased to nine for each variant of 
N. gonorrhoeae. Starting with three biological replicates for each strain, each of 
these were used to inoculate three A549 cultures resulting in three technical 
replicates for each biological replicate. This provided a total of nine replicates for 
WT and nine replicates for ΔfitAB for extraction at both 10 hours and 14 hours post-
gentamicin treatment (section 3.2.3). RNA was extracted from each of these 
samples (section 3.2.5.5) with 0.2 U µl-1 DNase in the DNase reaction. RNA from 
all the biological replicates was pooled at the end of the RNA extraction.  
The increase in bacteria greatly improved the amount of RNA extracted (Table 3-6). 
As previous concentrations determined by NanoDropTM differed greatly from that 
determined by the Agilent 2100 Bioanalyser, we measured the concentration using 
a Qubit® RNA BR assay kit (see section 3.2.4.4) as well. The Qubit® RNA BR 
analysis measures the concentration of intact RNA rather than free ribonucleotides. 
The concentration of RNA measured by this technique was outside the 
concentration range measureable by the Qubit® RNA BR assay (> 1200 ng µl-1). 
Although an exact concentration could not be given by the Qubit® assay, this result 
indicated there was plenty of intact RNA that should meet BGI concentration 
requirements. The absorbance ratios at OD260/280 and OD260/230 were all greater 
than 2.0 (Table 3-6) indicating the RNA samples were pure with no contaminating 
DNA.  
The samples were sent to BGI and independent tests using an Agilent 2100 
Bioanalyser were carried out. The resulting concentrations were, again, lower than 
the NanoDropTM measurements (Table 3-6) but still surpassed the RNA sequencing 
requirements. Unfortunately, the RIN values were all below 7.0 (Table 3-6) so 
sequencing was not recommended due to the possibility of library prep failure. 
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Table 3-6. RNA concentrations, OD260/280 and OD260/230 ratios, as measured by 
NanoDropTM and Agilent 2100, of the second batch of samples sent to BGI. 











WT 10hr 1560.5 2.06 2.01 620 5.9 
ΔfitAB 
10hr 
2138.7 2.08 1.91 1340 4.2 
WT 14hr 2791.1 2.09 2.12 1760 5 
ΔfitAB 
14hr 
1634.0 2.06 2.01 1650 6.7 
 
Subsequent intracellular replication assays and RNA extraction attempts failed to 
produce RNA that passed the sequencing requirements. After consultation with Prof. 
So and Dr Cherie Blenkrion, an expert in RNA sequencing, a decision was made to 
sequence the RNA from the last batch of samples sent to BGI (Table 3-6), despite 
the low RIN values. Unfortunately, the Illumina Ribo-zero rRNA Removal Kit used 
to deplete ribosomal RNA prior to library preparation was discontinued just prior 
to our decision to go ahead with sequencing. Other available rRNA depletion kits 
are yet to be trialled by BGI for sequencing N. gonorrhoeae RNA, so RNAseq is 
currently on hold.  
3.4 Conclusion 
The VapBC TA system, FitAB, decreases intracellular replication of 
N. gonorrhoeae. The population of fitAB gene deletion strains, within human 
epithelial cells, more than doubles in size over a four-hour period whilst WT 
bacteria remain at a slow, steady state of growth. Following rapid replication, fitAB 
gene deletion strains undergo a sudden cell death event, resulting in a dramatic 
decline in population. This is the most pronounced phenotype seen by a single TA 
mutant. In other bacteria, the difference in growth between vapBC deletion strains 
and the WT bacteria is much more subtle (McKenzie et al., 2012b), and the sudden 
cell death event see for N. gonorrhoeae ΔfitAB has only been reported for an 
M. smegmatis triple TA deletion mutant (Frampton et al., 2012). Despite having 
three other Type II TA systems, MazEF, RelBE and HicAB, it is evident FitAB 
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regulates growth of N. gonorrhoeae within human epithelial cells and is essential 
for sustaining long term survival of the population during infection.  
An optimised method has been established for the extraction of RNA from 
N. gonorrhoeae grown within human epithelial cells. We have obtained RNA from 
WT and fitAB gene deletion strains of N. gonorrhoeae at different time-points 
during an intracellular replication experiment and this is currently awaiting 
sequencing and transcriptome analysis. 
3.5 Future Research 
The intracellular replication experiment will be repeated using cervical cells instead 
of A549 human lung epithelial cells to evaluate whether FitAB has the same effect 
in a cell line more relevant to N. gonorrhoeae infection.  
The RNA will be sequenced to determine the transcriptomes of each strain of 
N. gonorrhoeae at different time-points. Transcriptomic analysis will determine 
differentially expressed genes between WT and fitAB gene deletion strains during 
different stages of intracellular growth. Transcripts that are up or down regulated 
will be applied to already established ribonuclease activity assays to determine if 
they are targeted by FitB. From these experiments we can determine the biological 




4 Chapter Four 
Conclusion 
N. gonorrhoeae, the causative agent of gonorrhoea, can cause asymptomatic 
infection by remaining within epithelial cells in a state of persistence (Workowski 
& Berman, 2007). The high rate of transmissible, asymptomatic infections in 
females and the acquisition of antibiotic resistance while in a persistent state are 
major contributing factors to the success of the pathogen. Little is known about the 
intracellular lifecycle of N. gonorrhoeae or the mechanisms of persistence. This 
thesis investigates the role of a toxin-antitoxin (TA) system in N. gonorrhoeae that 
regulates intracellular growth and produces a persistent phenotype.  
TA systems consist of a stable toxin and a relatively unstable antitoxin, forming an 
inactive complex when both counterparts are expressed together. When the 
antitoxin degrades, the free toxin impedes cell growth and, in some cases, causes 
cell death. Despite being toxic to cells, TA systems are abundant in prokaryotes and 
archaea, which begs the question, what is the function of TA systems and why are 
they so important?  
Several functions have been proposed for TA systems since they were first 
discovered over 30 years ago. The first TA systems described were encoded on 
plasmids (Gerdes et al., 1986) and proposed to be plasmid maintenance modules. 
If segregants did not contain the plasmid, the antitoxin could not be expressed and 
replenished, leaving free toxin which would kill the cell. This function was 
questioned when TA loci were discovered on bacterial chromosomes (Gerdes et al., 
2005; Pandey & Gerdes, 2005). For some chromosomal TA systems, they were 
found within or linked to MGEs (Cambray et al., 2010) and the proposed function 
was to maintain these MGEs in segregate cells (Hernández-Arriaga et al., 2014). 
Many chromosomal systems, however, are not linked to MGEs and are often found 
in multiple copies throughout bacterial genomes, for example, M. tuberculosis has 
80 chromosomal TA systems (Sala et al., 2014). An abundance of these TA systems 
suggests they have more complex functions than initially thought. 
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Many chromosomal TA systems, particularly those belonging to the Type II family, 
have been characterised as stress-response elements (Christensen et al., 2003; 
Gerdes, 2000). During periods of nutritional stress, chromosomal TA systems 
disrupt global translation of proteins and inhibit growth of the population 
(Christensen et al., 2001; Gerdes, 2000; Jørgensen et al., 2009). This response has 
been associated with the formation of persister cells to ensure the ultimate survival 
of bacterial populations (Amitai et al., 2009; Coussens & Daines, 2016; Jørgensen 
et al., 2009). As no TA system specific to N. gonorrhoeae has been characterised 
before, we wanted to characterise the function of FitAB, a Type II TA system found 
in the genome of N. gonorrhoeae, and assess whether it plays a role in persistence.  
FitAB, is named after its fast intracellular trafficking phenotype (Hopper et al., 
2000) and belongs to the VapBC TA superfamily. Many VapC proteins have been 
characterised as sequence-specific ribonucleases (McKenzie et al., 2012b; Sharrock 
et al., 2018; Winther et al., 2016; Winther & Gerdes, 2011). We have determined 
that FitB is a metal-dependent ribonuclease, targeting single-stranded RNA in a 
sequence-specific manner. FitB preferentially cuts RNA with a certain secondary 
structure but will bind to an array of single-stranded RNA fragments regardless of 
structure. FitB cuts RNA pentaprobes, which are approximately 160-nt long, but, 
unlike other VapC proteins, will not cut shorter RNA oligos of the same sequence. 
As FitAB is the only VapBC system in N. gonorrhoeae, it is likely the targeted 
sequence and secondary structure motif is highly specific to avoid off-target RNA 
cleavage.   
We performed intracellular replication experiments to characterise the growth of 
N. gonorrhoeae wild-type and fitAB gene deletion strains within epithelial cells. In 
the fitAB deletion strain, intracellular replication is markedly faster than the 
wild-type strain. Between six and ten hours after gentamicin treatment  the 
population of the fitAB deletion strain within the epithelial cells more than doubled, 
while growth of the wild-type population was delayed, doubling in size after 
14 hours. This is the most pronounced difference in intracellular replication rate 
between wild-type and a single TA deletion mutant that has been characterised. In 
other bacteria, deletion of a VapBC system resulted in faster growth but the 
differences between that and wild-type were much more subtle (McKenzie et al., 
2012b). 
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Interestingly, by 14 hours, the population of the fitAB deletion strain had declined 
dramatically suggesting the occurrence of a sudden cell death event. This phenotype 
has only been reported once before, for an M. smegmatis triple TA mutant in which 
three different TA loci, mazEF, vapBC and phd/doc, were deleted (Frampton et al., 
2012). The mutant population experienced a sudden cell death event after a period 
of normal growth (Frampton et al., 2012). This phenotype seen for N. gonorrhoeae 
suggests FitAB is important for regulating intracellular replication of 
N. gonorrhoeae and is essential for long term survival of the population during 
infection.  
We extracted RNA from N. gonorrhoeae at different time-points during the 
intracellular replication experiment. This is awaiting sequencing and transcriptomic 
analyses. Once we have transcriptome data from the fitAB deletion mutant and wild-
type strains, we can determine what transcripts are up or down regulated. Alignment 
of these transcripts with the biochemically determined FitB target cut site(s) will 
allow us to deduce the biological targets. We will apply the transcripts as substrates 
in the already established ribonuclease activity assays to confirm whether or not 
they are targets of FitB. This will help us determine the function of FitAB in 





Appendix A: Gene & Protein Information 
FitA (NGO0908) Information 












FitA Protein Sequence 
MASVVIRNLSEATHNAIKFRARAAGRSTEAEIRLILDNIAKAQQTVRLGSM
LASIGQEIGGVELEDVRGRNTDNEVSL 
78 amino acids 
Molecular weight: 8.43 kDa 
Theoretical pI: 6.57 
FitB (NGO0907) Information 














139 amino acids 
Molecular weight: 15.3 kDa 
Theoretical pI: 5.75 
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147 amino acids 
Molecular weight: 16.37 kDa 
Theoretical pI: 6.17 
FitAB Operon (NGO0907/8) Information 
FitAB operon contains genes fitA and fitB as above with an overlapping nucleotide 
(highlighted green). 





















271 amino acids 
Molecular weight: 23.72 kDa 
Isoelectric point: 5.97 
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225 amino acids 
Molecular weight: 24.79 kDa 
Isoelectric point: 6.25
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Appendix B: RNA Pentaprobe and Oligonucleotide Information 
B.1. Pentaprobe Sequences with Flanking Vector Sequence 
DNA sequence including flanking regions from pcDNA3 plasmid. The pentaprobe 
sequence is highlighted yellow. 
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B.2. Pentaprobe Secondary Structures 
Pentaprobe secondary structures were predicted for the pentaprobe sequence 
including the flanking sequence using RNAfold from the Vienna RNA Secondary 
Structure Server. Nucleotide colours indicate the probability of base-pair folding 























B.3. Oligonucleotide Sequences 
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Appendix C: Raw Data 
The following is raw data relating to Chapter Three.  
Table C-1. Intracellular bacteria cell counts in cells.ml-1 for each biological replicate 
(numbered 1-3) at each time point (hours post-gentamicin treatment), corresponding 
to figure 3-2. 
 WT ΔfitAB  
Time (hours) 1 2 3 1 2 3 
0 240000 240000 226667 1533333 53333 120000 
6 73333 180000 313333 46667 40000 46667 
8 133333 220000 86667 53333 46667 53333 
10 186667 40000 173333 46667 46667 273333 
14 453333 146667 193333 26667 33333 13333 
24 100000 40000 126667 6667 20000 26667 
 
Table C-2. Intracellular bacteria cell counts normalised as percent of zero hour for 
each biological replicate (numbered 1-3) at each time point (hours post-gentamicin 
treatment) and P values, corresponding to figure 3-2. P values are recorded as 
calculated using the Holm-Sidak method in Prism. 
 WT ΔfitAB   
Time (hours) 1 2 3 1 2 3 P value 
0 100.00 100.00 100.00 100.00 100.00 100.00  
6 30.56 75.00 138.24 30.43 75.00 38.89 0.39 
8 55.56 91.67 38.24 34.78 87.50 44.44 0.80 
10 77.78 16.67 76.47 30.43 87.50 227.78 0.40 
14 188.89 61.11 85.29 17.39 62.50 11.11 0.13 





















Table C-3. Intracellular bacteria cell counts normalised as percent of zero hour for each biological replicate (numbered 1-3) at each time 
point (hours post-gentamicin treatment) and P values, corresponding to figure 3-3. P values are recorded as calculated using the Holm-Sidak 
method in Prism. 
 
WT ΔfitAB  
Time (hours) 1 2 3 4 5 6 1 2 3 4 5 6 P value 
0 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00  
6 20.90 37.74 37.50 30.56 75.00 138.24 58.62 63.64 66.67 30.43 75.00 38.89 0.96 
8 25.37 35.85 25.37 55.56 91.67 38.24 113.79 109.09 127.08 34.78 87.50 44.44 0.05 
10 59.70 56.60 59.70 77.78 16.67 76.47 182.76 221.21 218.75 30.43 87.50 227.78 0.01 
14 - - - 188.89 61.11 85.29 - - - 17.39 62.50 11.11 0.13 
24 77.61 141.51 116.42 41.67 16.67 55.88 25.86 39.39 39.58 4.35 37.50 22.22 0.04 
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Table C-4. Intracellular bacteria cell counts in cells.ml-1 for each biological replicate 
(numbered 1-3) at each time point (hours post-gentamicin treatment), corresponding 
to figure 3-4. 
 WT ΔfitAB 
Time (hours) 1 2 3 1 2 3 
0 7466.67 9666.67 9533.33 11133.3 10333.3 10466.6 
6 3733.33 5000.00 4800.00 7800.00 7666.67 6533.33 
8 3533.33 4933.33 6266.67 9266.67 7800.00 7733.33 
10 4133.33 5400.00 5066.67 8000.00 8000.00 7400.00 
14 7266.67 7600.00 7333.33 2733.33 6466.67 7866.67 
24 14266.67 12066.67 11600.00 12666.6 10866.6 11866.6 
 
Table C-5. Intracellular bacteria cell counts normalised as a percent per zero hour 
for each biological replicate (numbered 1-3) at each time point (hours post-gentamicin 
treatment) and P values, corresponding to figure 3-4. P values are recorded as 
calculated using the Holm-Sidak method in Prism. 
 WT ΔfitAB  
Time (hours) 1 2 3 1 2 3 P value 
0 100.00 100.00 100.00 100.00 100.00 100.00  
6 50.00 51.72 50.35 70.06 74.19 62.42 0.01 
8 47.32 51.03 65.73 83.23 75.48 73.89 0.02 
10 55.36 55.86 53.15 71.86 77.42 70.70 0.00 
14 97.32 78.62 76.92 24.55 62.58 75.16 0.14 
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